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Abbreviations and Acronyms 
Access and Benefit 
 Sharing/ABS
Access to Genetic Resources and the Fair and Equitable  Sharing 
of Benefits Arising from their Utilization 
Art., Arts. Article, Articles
Associated Traditional 
Knowledge/ATK
Traditional Knowledge Associated with Genetic Resources 
Bonn Guidelines Bonn Guidelines on Access to Genetic Resources and Fair and 
Equitable Sharing of the Benefits Arising out of their Utilization 
CBD Convention on Biological Diversity
CETAF Consortium of European Taxonomic Facilities 
CGIAR Consultative Group on International Agricultural Research
CITES International Convention on the Trade with Endangered Species
FOEN Swiss Federal Office of the Environment
GR Genetic Resources 
IARC International Agriculture Research Centres
IGC Intergovernmental Committee on Intellectual Property and 
Genetic Resources, Traditional Knowledge and Folklore (WIPO)
International Treaty International Treaty on Plant Genetic Resources for Food  
and Agriculture
IPEN International Plant Exchange Network
MAT Mutually Agreed Terms
MTA Material Transfer Agreement
Multilateral System/MLS Multilateral System for ABS of the International Treaty 
Nagoya Protocol/NP Nagoya Protocol on Access to Genetic Resources and the Fair 
and Equitable Sharing of Benefits Arising from their Utilization 
to the Convention on Biological Diversity
NCHA Federal Act on the Protection of Nature and Cultural Heritage 
(NHG, LPN)
PGRFA Plant Genetic Resources for Food and Agriculture
PIC Prior Informed Consent
SMTA Standard Material Transfer Agreement
WIPO World Intellectual Property Organization
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Foreword 
It is a great privilege and pleasure to write a few lines to wel-
come the new good practice guide for academic research on 
access and benefit sharing (ABS). Having followed the sci-
entific and political process on ABS for more than two dec-
ades, it is gratifying to see this guide move the discussion 
on ABS and its implications for academic research into the 
reality of scientific enquiry and pursuit in our societies. 
In 1992, the international community of states established 
the Convention on Biological Diversity (CBD). The ABS 
principles stipulated in the CBD reached more operational 
specificity in the Nagoya Protocol in 2010. There the meas-
ures to implement the CBD principles are well specified. 
Moreover, in 2004, the International Treaty on Plant Genetic 
Resources for Food and Agriculture (International Treaty) 
complemented the conceptual and operational thinking on 
ABS. This guide is based on these three pillars. Through its 
wide-spread and thoughtful application in daily academic 
practice, it will be validated for its applicability and effi-
ciency. 
Governed by the present guide, sensitivity to ABS will 
become an essential part of enabling ethically and soci-
etally responsible academic research in partnership across 
systems and cultures by taking into account the prevail-
ing realities of our societies and the countless global chal-
lenges. Clearly, the guide helps ensure good scientific 
practice that is compatible with our Swiss legislation; it 
specifies procedures and approaches to integrate ABS in 
day-to-day research and to effectively meet the require-
ments of the implementation of the Nagoya Protocol in the 
framework of the Swiss legal order. 
ABS is strongly based on a contractual understanding in 
which interests and concerns of users and providers are 
not only discussed but reconciled for a responsible, ethi-
cally acceptable and science-enhancing way forward. Con-
sequently, living according to ABS in such a forward look-
ing way removes bottlenecks or overt contradictions and 
builds trust among all partners, thus rendering partnership 
even more effective. 
I sincerely congratulate the authors and their teams who 
have carefully established the guide through an effective 
process of consultation that will assure acceptance and 
application. Application will – in turn – contribute to the 
continuous and harmonic validation of the guide, already 
supported by the three conceptual and legal pillars, the 
CBD, the Nagoya Protocol and the International Treaty but 
challenged by the changing dynamics of science, research 
and development. It is only through the continuous assess-
ment and validation of our scientific practice that we 
remain responsible and ethically coherent to the societies 
and partners with whom we have the privilege to work. 
It is in this spirit, that I thank you for disseminating this 
ABS guide. I wish you stimulating reading and discussion 
as you consult its valuable content and translate it into your 
daily academic practice.
Marcel Tanner
President SCNAT
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1 Purpose of the Manual
The access and benefit-sharing (ABS) principles were agreed 
upon by the international community of States in the Con-
vention on Biological Diversity1 (CBD) in 1992. In 2010, the 
parties to the CBD adopted the Nagoya Protocol2 that spells 
out in more detail the measures its Parties should take to 
implement ABS principles. The third instrument covering 
ABS measures is the International Treaty for Plant Genetic 
Resources for Food and Agriculture3 (International Treaty, 
2004). These instruments need to be implemented on the 
domestic level by their Parties. Therefore, when accessing 
genetic resources (GR) or associated traditional knowledge, 
and utilizing them in research in states that are Parties to 
these conventions, scientists must respect the domestic leg-
islation and regulatory requirements of the providers of the 
resources or knowledge as well as those of Parties where 
research is carried out. 
The rules on “Access and Benefit-sharing”4 apply to com-
mercial as well as to non-commercial research. A scien-
tist doing basic or applied research on biological material 
or traditional knowledge associated to this material, must 
comply with the respective regulations. The goal of this 
manual is to enable researchers to act in conformity with 
these regulatory requirements. It provides information on 
the background, the procedures in access and benefit-shar-
ing and the responsibility of academic research. It explains 
the steps to be taken when accessing genetic resources for 
research purposes abroad, in-situ in the country of origin, 
or ex-situ in public collections, within a research institu-
tion, or from third persons. It presents the legal obligations 
of non-commercial academic researchers according to the 
1 www.cbd.int 
2 Nagoya Protocol on Access to Genetic Resources and the Fair and Equitable 
Sharing of Benefits Arising from their Utilization to the Convention on Biological 
Diversity  www.cbd.int/abs
3 www.planttreaty.org
4 “Access to genetic resources and the fair and equitable sharing of benefits arising 
from their utilization.“
Academic 
research needs to 
 comply with ABS 
 requirements
Swiss legislation and the ethical principles of good scien-
tific practice where the former do not apply.
These guidelines are addressed to researchers as well as research 
managers and heads of departments; they provide essential infor-
mation for the responsible organizational units in academic insti-
tutions. 
Switzerland has ratified the CBD, the Nagoya Protocol and 
the International Treaty. Corresponding legislation is in 
place and applies also to academic research. 
Benefits of ABS for research 
A set of accepted and operational protocols is essential for research-
ers working across international borders and will enhance collabo-
rative research among countries. Access to genetic resources and 
associated traditional knowledge for academic research may become 
easier as the procedures increase transparency and encourage trust 
between stakeholders.
How to use this brochure 
This Good Practice Guide gives a general overview of the ABS sys-
tem and its implications for academic research. It intends to provide 
comprehensive information to assist scientists and research insti-
tutions in planning and executing research projects that include 
genetic resources and associated traditional knowledge. 
Note: The Good Practice Guide contains recommendations. They do 
not replace legally binding obligations for researchers according to 
domestic ABS legislations or regulatory requirements in countries 
providing genetic resources.
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Table I: Overview of the stakeholders involved in Access to 
Genetic Resources and Associated Traditional Knowledge 
and steps to take. 
The ABS system covers genetic resources and associated tradi-
tional knowledge situated in any provider country that is party 
to the CBD or to the CBD and the Nagoya Protocol. The provider 
country acts through special institutions, namely the National 
Focal Point and one or more  Competent  National Authorities. In 
the case of associated traditional knowledge, the Indigenous and 
Local  Communities that are holders of the knowledge are also 
involved. 
2 Essentials of Access and Benefit- 
 sharing for academic research 
2.1 What is Access and Benefit-sharing? 
The CBD recognizes that States have sovereign rights over the 
genetic resources found within their national jurisdiction. Therefore 
they are entitled to define the modality of access to such resources 
for research purposes and for their subsequent utilization. This 
includes the fair and equitable sharing of the benefits aris-
ing out of the utilization of genetic resources. In turn and 
in line with Article 15 of the CBD, the parties should do 
their best to facilitate access to their genetic resources “for 
environmentally sound uses”. These principles are sub-
stantiated in the Nagoya Protocol and implemented in the 
domestic legislation and regulations of the countries pro-
viding the genetic resources. It is up to the countries to 
decide whether they require the fulfilment of ABS obliga-
tions for accessing their genetic resources. 
If you intend to do research on genetic resources and/or 
associated traditional knowledge in a country requiring 
ABS procedures for academic research, your research needs 
to be covered by the Prior Informed Consent (PIC) and the 
Mutually Agreed Terms (MAT) of the provider country. If 
your research includes associated traditional knowledge, 
the PIC and possibly MAT of its holders may be required 
too. The respective conditions depend on the domestic leg-
islation or rgulatory requirements of the provider country. 
This is true whether you access the genetic resources 
in-situ, from the field, or ex-situ, from an institution or 
third person. 
The following graph gives a simplified overview of the per-
sons and the steps involved in access to genetic resources 
and associated traditional knowledge. It also introduces the 
pertinent terminology. 
54
2
Resources Access Utilization Benefit Sharing
Traditional Knowledge of 
indigenous and local com-
munities about specific 
qualities of the biological 
material: Associated Tradi-
tional Knowledge (ATK)
Biological material needed 
for research: 
Genetic Resources (GR) 
1
3
Based on the information 
received, the Provider  
consents to the research: 
He/she gives his/her Prior 
Informed Consent (PIC) 
User submits information 
on project required by the 
Provider to get permission  
to do research on the 
 biological material (and asso-
ciated traditional knowledge) 
= to apply for access   
non-commercial research Non-monetary  
benefits 
R & D 
for commercial ends 
Monetary benefitsCommercialis ation of 
products 
State holding  
the  biological 
material  
= Provider Country
 
Community  
hol ding ATK 
= Provider 
acting through
National Focal Point;
Competent National Authority
(and Holders of ATK) (providers)
acting through
Project leader
Legal Department/ABS specialist/
Technology Transfer
Researcher 
= User 
Provider and User 
negotiate the detailed 
conditions, in particular 
on utilization and benefits 
to be shared: Mutually 
Agreed Terms (MAT)
Never utilize 
genetic resources 
before verifying 
the  conditions 
for  access and 
utilization
You, as the User, check on the ABS Clearing House website5 and 
inquire with the ABS Focal Point about conditions for access and 
the respective procedures, and apply for access to the  genetic 
 resources and/or associated traditional knowledge. The provider 
country, acting through its  Competent National Authority, gives 
its Prior Informed Consent (PIC); together user and provider nego-
tiate the Mutually Agreed Terms (MAT). 
5 https://absch.cbd.int
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The Prior Informed Consent is, in most cases, a unilateral 
administrative permit given by the Competent National 
Authority of the provider country and – if applicable – by 
additional providers, such as an indigenous or local com-
munity, to an individual or an institution prior to accessing 
genetic resources. Depending on the domestic legislation or 
regulatory requirements of the provider country, it might be 
required in addition to the research permit (cf. Appendix I). 
On this basis, in a second step, the Mutually Agreed Terms are 
negotiated. The MAT are a bilateral (private law) contract 
between providers and users. They establish the conditions 
of access and utilization of the resources and the benefits 
to be shared. The contract needs to respect the regulatory 
requirements of the country providing genetic resources 
and/or associated traditional knowledge and of the country 
where such resources or knowledge will be utilized. 
Overview of main actors and instruments:
Provider country: Party providing genetic resources that is the coun-
try of origin of such resources or that has acquired the resources in 
accordance with the CBD (Art. 15 CBD, Art. 6 NP). 
Provider: Institution that, according to the domestic legislation or reg-
ulatory requirements of a provider country, has the competence to 
grant access. It may be different from the Competent National Author-
ity (i.e. an institution delegated by the competent authority) or it may 
act in addition to the Competent National Authority (Holders of ATK, 
decentralised agency). 
National Focal Point: Provides information on authorities/communi-
ties to contact, conditions for access and procedures to observe. 
Competent National Authority: Agency in the provider country that is 
entitled to grant access, namely to issue the PIC and to negotiate and 
conclude the MAT according to its national regulatory requirements.
Prior Informed Consent: Unilateral permission issued by the Compe-
tent National Authority to an individual or institution seeking access 
to genetic resources. 
Mutually Agreed Terms: Agreement between provider country/pro-
vider of genetic resources and traditional knowledge and the users, 
on the conditions of access and utilization of the resources and on 
the benefits to be shared. 
 
Key to  ensuring 
good ABS 
 practice is to 
understand the 
implementa-
tion of the ABS 
provisions by 
the country that 
provides the 
resources.
The SCNAT’s publication “Agreement on Access and Benefit-sharing 
for Academic Research”6 offers a toolbox to help set up the Mutually 
Agreed Terms. It contains Model Contractual Clauses and is designed 
for the use by providers of genetic resources and associated traditional 
knowledge and for academic researchers. 
The toolkit covers the essential elements that need to be considered 
in the case of access for academic research. It aims to meet the 
needs of both the providers and the users of the genetic resources. 
The kit includes optional clauses allowing to adapt a Mutually Agreed 
Terms contract to various cases of biodiversity research and to the 
different needs of providers. 
The “ABS-Agreement toolkit” is meant to serve as a template that can 
be applied to fill the gap where no national tools are available. The 
text may also be used as a checklist for items that need to be agreed 
upon when negotiating Mutually Agreed Terms. 
2.2 Steps involved in ABS:  
 where to find the pertinent information 
The following list gives a brief overview of the steps involved 
in access to genetic resources by academic researchers. The 
numbers refer to the chapters of this manual. For detailed 
step-by-step recommendations, refer to chapter 2.5. 
Accessing Genetic Resources in-situ and/or Associated 
 Traditional Knowledge
Chapters 
1. Assess the relevance of ABS for your intended  
 research 
2.1; 5.3-5.5
2. If your research falls under ABS, go to  
 the ABS Clearing House to: 
5.6
 a. Obtain the contact details of the focal point  
  of your provider country; 
 b. Check whether the provider country is Party  
  to the Nagoya Protocol and has  
  ABS regulation in place (relevant for  
  the application of the Swiss legislation). 
3
6 www.naturalsciences.ch/organisations/biodiversity/abs/publications
Useful tip
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3. Contact the ABS National Focal Point of your  
 provider country and inquire about: 
5.6
 a. Conditions to apply for PIC and MAT; 2.1; 5.6
 b. Other specifics of the national legislation/ 
  regulation (e.g. specific conditions for utilization,  
  benefit-sharing). 
4. Inquire which additional permits may be necessary  
 (e.g. research permits, exportation permits). 
Appendix I
5. Apply for PIC. 
6. Negotiate MAT. 
7. During research, comply with MAT and the  
 legislation of your provider country. Comply  
 with Swiss legislation, if applicable. 
3
8. Share benefits as agreed in the MAT. Appendix III 
9. After finalization of the research, proceed with  
 the collected material as agreed in the MAT. When  
 transferring material to ex-situ facilities or third  
 persons, include relevant ABS documentation.
3
 
Additional points when accessing genetic resources ex-situ
1. Inquire with the ex-situ facility about the ABS  
 conditions for the genetic resource you intend  
 to access: 
2.4; 2.5
 a. From a non-registered facility, verify its  
  legitimate acquisition, the right of the facility  
  to transfer the genetic resources, and whether  
  your intended research is covered by the PIC and  
  MAT of the provider. 
 b. From a registered facility, verify whether PIC  
  and/or MAT of the provider covers your intended  
  research. 
2.5; 3.1
 c. If your research is covered, comply with PIC  
  and /or MAT. If not, apply for new PIC and MAT  
  with the provider country.  
2.1; 5.6
2. Comply with the MTA of the collection. 
 
Additional obligations according to the Swiss legislation  
(Due Diligence)
 
1. Store proof of legitimate access (PIC, MAT)  
 according to the requirements of Due Diligence. 
3.1
2. Hand over all relevant documentation  
 to subsequent users.
3.1 
2.3 The meaning of fundamental terms7
In the context of ABS, the term genetic resources has a broad 
meaning: It refers to “any material of plant, animal, micro-
bial or other origin containing functional units of heredity 
and that is of actual or potential value” (Art. 2 CBD). These 
genetic resources fall under the rules on ABS if they are utilized 
to “conduct research and development on the genetic and/
or biochemical composition of genetic resources, including 
through the application of biotechnology …” (Art. 2[c] NP). 
Accordingly, ABS does not apply to biological material con-
taining genetic resources that is used as commodity. 
The genetic resources can be wild, domesticated or culti-
vated. ABS applies to access to genetic resources in-situ as 
well as ex-situ (Art 2 CBD). Human genetic resources are 
not covered by the CBD.  
The Plant Genetic Resources for Food and Agriculture (PGRFA) are 
defined as any “genetic material of plant origin of actual or 
potential value for food and agriculture” (Art. 2, Interna-
tional Treaty). They are subject to the International Treaty 
on Plant Genetic Resources for Food and Agriculture (Inter-
national Treaty). 
The ABS-system also applies to access to traditional knowledge 
associated with genetic resources that is held by indigenous and local 
communities. There is no internationally legally binding defi-
nition of traditional knowledge. The term according to inter-
national declarations refers to “the traditional knowledge, 
innovations and practices of indigenous and local commu-
nities embodying lifestyles relevant for the conservation and 
sustainable use of biological diversity”.8
7 For more information refer to chapter 5 and Appendix II.
8 Akwé: Kon voluntary guidelines for the conduct of cultural, environmental and 
social impact assessment regarding developments proposed to take place on, 
or which are likely to impact on, sacred sites and lands and waters traditionally 
occupied or used by indigenous and local communities, II. Use of terms, par.6, let. h. 
 www.cbd.int/traditional/guidelines.shtml 
Utilization of 
genetic resources 
means to conduct 
research and 
development on 
their genetic and/
or biochemical 
 composition
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2.4 Which legal framework applies  
 to your research? 
At the international level, different legal frameworks exist for 
the utilization of genetic resources, in particular the CBD, the 
Nagoya Protocol and the International Treaty. These frame-
works have to be implemented at national level by their Par-
ties. Yet, not all states are Parties to all three Conventions. 
Also, there are countries that do not require ABS procedures 
for access to their genetic resources and associated traditional 
knowledge. This leads to different legal situations for ABS. 
The international legal framework that applies to your research, 
as well as its implementation on the national level, is bound to 
influence the ease of access. The following decision trees can 
help you identify which one applies to your planned research. 
They may assist your strategic decisions regarding the choice 
of country and source of biological material for your research.
The first decision tree in Table II (see p. 19) depicts different 
scenarios regarding in-situ access to genetic resources abroad, 
namely in
1. Countries that are party to the CBD and the Nagoya Pro-
tocol with ABS regulation in place; 
2. Countries that are party to the CBD and the Nagoya Pro-
tocol without ABS regulation in place;9 
3. Countries that are party to the CBD only (CBD-only coun-
tries) with ABS regulation and/or infrastructure in place;
4. Countries that are party to the CBD only (CBD-only 
countries) without ABS regulation and/or infrastruc-
ture in place. 
Countries that have ratified and implemented the Nagoya Protocol 
may have the most transparent procedures for access and legal 
security. Researchers may expect challenges in CBD-only countries 
that lack ABS regulation and corresponding administrative infra-
structure. 
9 This is relevant for the application of the Swiss Due Diligence requirements that 
only apply to utilization of resources in countries that are parties to the Nagoya 
Protocol and that have ABS regulatory requirements in place.
Useful tip
The second decision tree in Table III (see p. 20) illustrates 
access ex-situ to genetic resources hosted in collections. 
Here, there is a difference between 
1. Access to PGRFA and access to all other genetic resources;
2. Access to PGRFA that are included in the “Multilateral 
System of Facilitated Access” (Multilateral System) and 
all other PGRFA. 
The Multilateral System of Access and Benefit-sharing  
of the International Treaty
The International Treaty established the Multilateral System of Access 
and Benefit-sharing. It provides easy access ex-situ to selected crop 
and forage varieties (listed in Annex I of the International Treaty10) 
for research, breeding and training in collections that are part of the 
Multilateral System11. Only the Standard Material Transfer Agreement 
(SMTA) needs to be signed.
For ex-situ access to genetic resources not included in the Multi-
lateral System, users have to follow the national ABS regulation of 
the country where the collection is located. In such cases, access 
will probably be simpler in countries that have ratified the Nagoya 
Protocol. 
If you do research with PGRFA listed in Annex I of the International 
Treaty, the easiest approach is to access the biological material 
through a collection that is part of the Multilateral System (see 
chapter 2, Appendix II; Appendix IV).
Some countries may establish a system of “registered collections” 
(see chapter 3.1) that manages their hosted genetic resources accord-
ing to ABS requirements to facilitate compliance. 
Other networks of collections provide facilitated access and exchange 
within their own organisation (for instance the International Plant 
Exchange Network, IPEN).12 
10  See www.planttreaty.org/content/crops-and-forages-annex-1 
11 See www.planttreaty.org/inclusions 
12 www.bgci.org/policy/ipen
Useful tips
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Is your resource a PGRFA? (Annex II)yes
no
Has your provider country ratified the Nagoya 
 Protocol? (Clearing-House https://absch.cbd.int)
Switch to “Access in CBD-only country”.  
No Due Diligence in Switzerland.
Does your provider country require ABS? 
(National Focal Point).
yes no
No ABS requirements for accessing the resources. 
 No Due Diligence in Switzerland.
Has your provider country ABS regulation in place? 
(Focal Point; Clearing-House) 
No Due Diligence requirement in 
Switzerland.
Switch to “Countries without ABS 
regulation”. 
Get information on the further procedure to get PIC and 
to negotiate MAT via the ABS Clearing-House: (National 
Focal Point of the provider country; ABS website of the 
provider country). 
The Swiss regulation on Due Diligence applies (chapter 
3.1). 
noyes
yes no
Access in NP country without ABS regulation 
Has your provider country defined   
a National Focal Point (Clearing-House)? 
Inquire about conditions for 
access and access procedures 
(National Focal Point).
No Due Diligence in Switzer-
land required. Comply with 
the instructions of the Focal 
Point and with good scientific 
practice. 
Check whether the Swiss Focal Point, or research partners in the  
potential provider country can give you a relevant contact. 
no
Consider carrying out 
your research in another 
country. 
yes
Inquire with the contact about con-
ditions and procedures for access, 
including: documentation to submit, 
authorities to address and other permits 
required. 
yesno
Access to genetic resources in CBD-only country 
Go to the ABS Clearing-House. Check if your provider  
country has defined an ABS Focal Point.
noyes
Contact the National Focal Point and inquire about 
conditions for access and access procedures. 
The Swiss regulation on Due Diligence does not 
apply. Comply with the instructions of the National 
Focal Point and to good scientific practice.
Check whether the Swiss Focal Point,  
or research partners in the potential provider 
country can give you a relevant contact. 
Consider carrying 
out your research in 
another country. 
Inquire with the contact about conditions and 
procedures for access, including: documen-
tation to submit, authorities to address and 
other permits required.
noyes
Check whether your research is subject to Access and Benefit-sharing requirements. 
(Chapter 2.1, and 5.3).
No ABS obligation.
no
PGRFA: Plant Genetic Resource for Food an Agriculture
International Treaty: International Treaty on PGRFA
PIC: Prior Informed Consent
MAT: Mutually Agreed Terms
CBD-only country: Country is Party to the CBD but not to the NP
Is your provider country party to the International  
Treaty? (www.planttreaty.org/list_of_countries)
The International Treaty 
applies:
Access ex-situ: see p. 18 
Access in-situ: national ABS 
legislation 
 
no
yes
yes
Table II: Access to genetic resources in-situUseful information sources for collections 
 –  Consortium of European Taxonomic Facilities (CETAF) Code of Con-
duct and Best Practices for Access and Benefit-sharing; includes 
three types of Standard Material Agreements; available at  
http://cetaf.org/taxonomy/publications
 –  World Federation for Culture Collection; TRUST – transparent 
user-friendly system of transfer; based on MOSAICC MICROOR-
GANISMS SUSTAINABLE USE AND ACCESS REGULATION INTERNA-
TIONAL CODE OF CONDUCT; September 2014; available at  
http://bccm.belspo.be/projects/trust 
 –  Global Genome Biodiversity Network; Best Practice for Access 
and Benefit-sharing; Code of Conduct; Standard Material Transfer 
Agreements; revised June 2015, available at  
http://wiki.ggbn.org/ggbn/Documents
2.5 Recommendations on how to proceed 
Step by step recommendations on access to genetic 
 resources in-situ and ex-situ 
Table IV (see p. 26) suggests the necessary steps for the 
implementation of a research project utilizing genetic 
resources. It branches off depending on whether the user 
acquires the genetic resources from the field (in-situ) or 
from an institution or a third person (ex-situ).
Researchers or users should inquire in the planning phase 
about the ABS conditions in the prospective provider coun-
try if they plan to access the biological material in-situ. If 
accessing genetic resources from an ex-situ facility, appli-
cation for new PIC and MAT with the provider country may 
be required if the documents that come with the biological 
material do not allow the transfer to a third person or the 
intended utilization.
Table IV focuses on academic research for non-commercial 
use. Nevertheless, it includes action for research and devel-
opment of potential commercial use to illustrate the genetic 
resources value chain and changes of research intent. 
Has the sample been collected after entry into  
force of the NP (12 October 2014)? 
Check whether your research is subject to Access and Benefit-sharing requirements
(chapter 3.1 and 5.4).
Is your resource included in the MLS of the Interna tional 
Treaty (chapter 2.4, chapter 5.4)? 
Is your resource a PGRFA? (Annex II) No ABS obligation.
yes no
yes no
Do you intend to access in a NP 
 country with ABS regulation?
Do you intend to access a resource in Switzerland or in the EU?
yesno
The Swiss Due Diligence 
obligation applies.
No Due Diligence in Switzerland. 
Comply with MTA.
No Due Diligence in Switzerland. 
Comply with MTA of the collection.
yesno
Do you intend to access the sample in a 
registered collection (chapter 3.1)? 
Researcher has to verify 
collection’s compliance 
with Due Diligence.
Compliance of the 
collection with Due 
Diligence is presumed.  
yesno
yesno
yesno
Is  the resource stored in an IARC? ABS conditions according  
to the national regulation/MTA.
Is the resource voluntarily included in the Multi lateral 
System? (www.planttreaty.org/inclusions)
The SMTA applies  
(chapter 3.2, chapter 5.4) 
The SMTA applies  
(chapter 3.2,  chapter 5.4)   
no yes no yes
no yes
ABS conditions according to the 
national regulation / MTA.
The SMTA applies.
Is your resource stored in a collection that is in cluded in the Multilateral 
System? (www.planttreaty.org/inclusions)
PGRFA: Plant Genetic Resource for Food an Agriculture
International Treaty: International Treaty on PGRFA
MTA: Material Transfer Agreement
NP: Nagoya Protocol
MS: Multilateral System on ABS
SMTA: Standard Material Transfer Agreement
IARC: International Agriculture Research Centres
Table III: Access to genetic resources ex-situ
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The genetic resource value chain and changes in the utilization  
(change of intent) 
It is possible that a genetic resource accessed for basic research is, at 
a later stage, utilized for research and development in a commercial 
context. 
Different scenarios are possible: The transfer of the genetic resources 
that are promising for further research might, 1) occur directly between 
researchers, 2) between different departments of a research institu-
tion, 3) between cooperating institutes, or 4) via internal or public 
collections. A consecutive project may be an immediate follow-up to 
the previous one, or be taken up only after some time has elapsed.
In ABS terms, this is called “change of intent.” While these cases are 
not frequent, in the event of future commercialization, the corre-
sponding PIC and MAT is imperative. 
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 – Reflect on options for benefit-sharing (solutions and ide-
as of the holders of associated traditional knowledge 
may seem unorthodox to you). Sharing of results in an 
academic form may not be adequate. 
Publication of results and data 
 – Acknowledge the provider country and/or the collection 
supplying the genetic resources as the source of the ge-
netic resources in all publications arising from their uti-
lization. This includes written and electronic publica-
tions and reports, including sequence data stored in 
online databases in the public domain.16 
 – When depositing sequence data, unique identifiers asso-
ciated with the provider (such as an Internationally Rec-
ognized Certificate of Compliance code) should also be 
submitted. 
 – If in the PIC/MAT for access to the genetic resources uti-
lized non-commercial use is specified, publication of the 
data should be accompanied by a statement that for uses 
other than non-commercial, the author/depositor of the 
data must be contacted and/or permission from the orig-
inal provider of the genetic resources must be sought. 
 – When publishing the results of research including Asso-
ciated Traditional Knowledge, acknowledge its source, 
unless otherwise agreed upon with the holders of that 
knowledge. Additional conditions of the provider coun-
try or the holders of the knowledge, such as clauses re-
garding sharing of the benefits resulting from the utiliza-
tion of the knowledge, must be added. In order to give 
their informed consent, the holders of the knowledge 
must be clearly informed that the knowledge will be 
published. They must be given the opportunity to de-
clare specific information as confidential for instance, 
for spiritual reasons, to prevent the loss of genetic re-
sources and/or to prevent unsafe or hazardous uses.
16 CETAF, Code of Conduct and Best Practice for Access and Benefit-Sharing, 2015.  
Accessible at http://cetaf.org/taxonomy/publications 
Access to Traditional Knowledge Associated to Genetic Resources 
In many countries access to Associated Traditional Knowl-
edge requires the PIC of its holders. Even in a country 
where there are no formal ABS requirements, ethical prin-
ciples need to be respected. Therefore, when your research 
involves access to Associated Traditional Knowledge: 
 –  Determine early whether the type of knowledge you 
want to access is subject to ABS for access to Associated 
Traditional Knowledge in the provider country. 
 –  Respect international law and ethical principles on 
rights of indigenous peoples; e.g. the United Nations 
Declaration on the Rights of Indigenous Peoples (2007),13 
the International Labour Organization Convention 169 
(1989),14 professional ethical codes such as the Code of 
Ethics of the International Society of Ethnobiology.15 
 –  Design your research to match the interest of the in-
volved communities. Prepare to communicate your re-
sults clearly and in a non-scientific way adapted to the 
customs of the community. 
 –  Clearly inform the involved community about your 
planned research and the expected results. 
 –  Record all ABS relevant steps; store the respective doc-
uments. 
 –  Respect the customary law, customs, traditions, values 
and practices of the holders of the Associated Tradition-
al Knowledge. 
 –  Respect the wish of the holders of Associated Tradition-
al Knowledge to keep specific parts of their knowledge 
confidential, for instance, for spiritual reasons, to pre-
vent the loss of genetic resources and/or to prevent un-
safe or hazardous uses. 
 –  Respond to requests for information from the involved 
communities and present the information in a suitably 
adapted form. 
13 https://daccess-ods.un.org/TMP/8351190.68622589.html 
14 www.ilo.org/dyn/normlex/en/f?p=NORMLEXPUB:12100:0::NO::P12100_ILO_
CODE:C169 
15 www.ethnobiology.net/what-we-do/core-programs/ise-ethics-program/code-of-
ethics/code-in-english 
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Recommendations for institutions 
The adoption of the Nagoya Protocol and its implementa-
tion by its Contracting Parties is expected to increase legal 
security and transparency for access and benefit-sharing 
and ease access procedures for academic research. Its mon-
itoring and compliance measures are essential to promote 
the confidence of providers. 
Since its inception, ABS has been based on bilateral rela-
tions between providers of genetic resources and their 
users. This means that a key element of the system is a 
contract between providers and users that stipulates the 
mutual rights and duties and the conditions for access.
The complexity of these contracts varies in relation to the 
project setting and the access situation: from simple Mate-
rial Transfer Agreements to complex contracts, for instance 
if decentralized entities (such as decentralised authorities 
or holders of traditional knowledge) need to be included or 
if access contracts are combined with contracts on research 
partnerships.
Negotiation and conclusion of contracts with external part-
ners is not new for most research institutions. Thus the 
conclusion of ABS agreements can be integrated into the 
existing organizational and procedural settings and order 
of competencies. 
However, in comparison with other contracts, access and 
benefit-sharing presents some specific features. These are 
worth considering in order to streamline the application 
for access and avoid time-consuming procedures at the 
expense of research time. This will also minimize adminis-
trative costs for the institution and alleviate the administra-
tive burden for project leaders and researchers. 
Among these features are the following: 
First, ABS formalities, i.e. the application for the Prior 
Informed Consent and the negotiation of the Mutually 
25Swiss Academies Reports, Vol. 11, No 4, 2016
Due to the need to track the resources in the downstream 
research and value chain, documentation is crucial. While 
documentation of the resources used in research is part 
of the scientific routine, Swiss (and EU) ABS legislation 
include some specific requirements (see chapter 3) regard-
ing content, storage and transfer of the documentation. In 
case of inquiries, e.g. by the provider country, the ABS doc-
umentation needs to be accessible via the institution. 
In sum, the following tasks arise during the lifespan of a 
research project:17 
1)  During the planning period, the relevance of ABS for 
the project needs to be assessed; in the affirmative case, 
and if there is flexibility regarding the sourcing of the 
genetic resources, the optimal partners (country, collec-
tion) ought to be evaluated and benefit-sharing options 
discussed. 
2)  In the preparatory period, the access procedure needs to 
be managed. This includes building contacts to the rele-
vant authorities; inquiring about requirements and con-
ditions; applying for PIC and concluding the MAT; stor-
ing the pertinent documents and/or concluding other 
relevant contracts. 
3)  During and after the conclusion of the research, com-
pliance with the MAT (in particular the benefit-sharing 
obligations) is essential. 
4)  The relevant documentation needs to be stored and main-
tained; if the genetic resource is stored, it needs to be 
safely linked to the documentation (see chapter 3). 
ABS is not only a legal challenge. Its implementation in an insti-
tution may also include strategic reflections and organisational 
measures. 
ABS procedures may be complex. A good overview of the 
ABS situation in the prospective partner countries and 
know-how in obtaining relevant information and experi-
ence are valuable assets. 
17  See also Table IV.
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Mutually Agreed Terms (MAT)
Benefit-sharing (BS)
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Agreed Terms, need to be concluded before accessing the 
resources. Otherwise, if the legal and administrative situa-
tion in the intended provider country is not clear, precious 
project time is lost to complicated negotiations before the 
resources can even be accessed. 
Second, it is up to the countries how they implement ABS. 
Therefore, the legal and procedural situation in the pro-
vider countries may differ: It might be clearer in countries 
that are Parties to the Nagoya Protocol and have implement-
ing legislation or regulation and institutions in place than 
in CBD-only countries and/or Parties to the NP that don’t 
have legislation/regulation and institutions in place (see 
2.4). If there is a choice regarding the geographical loca-
tion for access, it may be preferable to choose a “well-or-
ganized” country or a country offering easy access for aca-
demic, basic research. 
An alternate solution might be to access the resources from 
a Swiss or European ex-situ facility – in particular from a 
registered collection (see 3.1) – if this is compatible with 
the research concept. 
Third, the administrative organisation of the ABS proce-
dures is up to the countries. The respective competen-
cies and duties may be assigned to an authority that is not 
familiar with matters of scientific research, for instance to 
a ministry responsible for trade matters. This means that 
more background information has to be offered than when 
negotiating with partners closer to sciences and research. 
Established relations with responsible people and good 
experiences help, as well as established cooperation with 
institutions in the provider country. 
The finances necessary for benefit-sharing may need to be 
integrated into the application for the funding of the pro-
ject. That means that at an early stage of the planning pro-
cess it must be clarified what benefit-sharing is possible; 
this may include early negotiations with prospective part-
ners. 
Therefore, it might be commendable to create an ABS spe-
cialised function, complementary or joined to the legal com-
petence that is capable of assisting the research units at an 
early stage in the project. This would allow for accumulating 
and concentrating knowledge, experience and, over time, 
could establish a partner network with providing countries. 
This specialised function could then operate as a pivotal 
point between researchers and prospective providers, thus 
unburdening the research units and providing support for 
developing the best ABS strategy. Tasks of the ABS special-
ist would include gathering information on relevant con-
tacts and the legal and administrative situation and required 
procedures in the envisaged provider country; identifying 
possible alternate solutions and the ensuing obligations. It 
would be up to the project leaders to assess the relevance of 
ABS at an early stage of the project and know how to proceed 
internally. To this end, they need to have a general overview 
on Access and Benefit-sharing and ensuing obligations. 
The following measures are recommended: 
 –  Define research units that are affected by ABS and pro-
vide for raising awareness and building capacity. The 
leaders of these units ought to be able to identify re-
search with potential ABS relevance and take further 
steps, i.e. inquiry with the ABS specialist. 
 –  Assign the function of ABS specialist to a member of a 
defined administrative unit. Allow for his/her capacity 
building. This specialist would assist the principal in-
vestigators in all questions related to ABS. 
 –  Organize storage and transfer of the required and addi-
tional documentation on the legitimacy of access. 
Advantages of institutions as partners in ABS 
For the providers/provider country it is important and advantageous 
to partner with an institution that is able to take responsibility for 
research, research products and utilization of genetic resources 
on a long-term basis. This secures control over the utilization of 
the genetic resources in case of a change of staff in the research 
units and/or in case of a “change of intent” – i.e. of the transition of 
research results into industrially-oriented R&D. 
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3 Implementation of the Nagoya   
Protocol and the International   
Treaty in Switzerland 
3.1 Implementation of the Nagoya Protocol 
Overview
Switzerland ratified the Nagoya Protocol on 11 July 2014, 
after the adoption of the respective legislation for its imple-
mentation, an amendment of the Federal Act on the Pro-
tection of Nature and Cultural Heritage (NCHA)18 (cf. in 
particular Arts 23n to 23q NCHA). This amendment of 
the NCHA entered into force with the Nagoya Protocol 
on 12 October 2014. The related Nagoya-Ordinance19 was 
adopted by the Federal Council on 11 December 2015 and 
entered into force on 1 February 2016.
The Swiss ABS regulations introduce the following meas-
ures: 
1. A Due Diligence requirement to assure that those who 
utilize genetic resources according to the Nagoya Proto-
col, or benefit directly from their utilization, respect the 
domestic legislation or regulatory requirements of the 
Party to the Nagoya Protocol that provides the resource 
and, if required, agree on conditions for benefit-sharing.
2. A requirement to notify compliance with the due dil-
igence obligation to the Federal Office for the Envi-
ronment (FOEN) before market authorization has been 
obtained or, if such authorization is not required, before 
the commercialization of products that have been devel-
oped on the basis of utilized genetic resources. 
3. The Due Diligence and notification requirements also 
apply to traditional knowledge of indigenous and local 
communities associated with genetic resources unless 
18 Of 1 July 1966 (Status as of 12 October 2014) Classified Compilation (SR) 451. 
 www.admin.ch/opc/en/classified-compilation/19660144/index.html 
19 Of 11 December 2015, SR 451.61. 
 www.admin.ch/opc/de/classified-compilation/20150120/index.html 
such traditional knowledge is already freely available to 
the public.
4. A requirement to document resources accessed in Swit-
zerland and the notification to the FOEN before market 
authorization has been obtained or, if such authorization 
is not required, before the commercialization of prod-
ucts developed on the basis of these genetic resources. 
The Swiss obligations of Due Diligence and notification apply to: 
genetic resources that (Art. 23n para 2 and Art. 25d NHCA):
 –  Have been accessed after 12 October 2014 (the entry into force 
of the Nagoya Protocol and of the NCHA);
 –  Originate from a country that
 · Is a Party to the Nagoya Protocol and
 · Has domestic access and benefit-sharing regulatory require-
ments in place. 
Associated Traditional Knowledge not freely available to the public 
(Art. 23p NHCA).
 
Due Diligence and notification: useful details 
In case of access in-situ in countries requiring PIC, the Due Dil-
igence obligation requires that the user must store infor-
mation related to the access and the utilization of genetic 
resources and/or Associated Traditional Knowledge. This 
information may be contained in the Internationally Rec-
ognized Certificate of Compliance or the documentation of 
PIC and MAT. This information must be passed on to subse-
quent users and – in case of commercialization – included 
in the notification to the FOEN.
Certificate of compliance 
The Internationally Recognized Certificate of Compliance serves as 
evidence that Prior Informed Consent has been granted and Mutually 
Agreed Terms on benefit-sharing have been concluded. It is consti-
tuted by a permit or its equivalent, issued by the provider country 
at the time of access and made available to the Access and Bene-
fit-sharing Clearing-House (ABSCH) according to a specified template. 
The certificate is published on the ABSCH. 
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If the user accesses the genetic resource ex-situ, he/she has to 
make sure that the collection, institution or third person 
has lawfully accessed the genetic resources. If the resources 
are accessed from a Swiss Registered or EU Registered Col-
lection, compliance with Due Diligence is facilitated, as the 
ex-situ collections will provide you with the necessary doc-
umentation. In both cases, the user has to verify that the PIC 
of the provider covers transfer of the material to a third per-
son as well as the planned research. If this is not the case, 
he/she has to obtain new PIC and MAT from the provider 
country corresponding to the planned utilization, or desist 
from utilizing the genetic resource. 
Registered Collection 
Collections can be important providers of genetic resources and 
associated traditional knowledge. In this function they can promote 
compliance of the users with ABS regulations. Collections that guar-
antee that the resources have been legally accessed and are well 
documented can be included in the voluntary register maintained 
by the FOEN. 
All information must be stored 
 – For ten years after having completed the utilization or 
after the generation of benefits and
 – As long as the resource or the resulting product is 
stored (Art. 3 para 5 Nagoya-Ordinance). 
 
In case of an obligation to notify (see above p. 34, 2.) this 
information must be notified to the FOEN. The user is 
obliged to submit all relevant documents as specified in 
Art. 4 of the ordinance. 
In addition, when applying for a patent in Switzerland, the 
patent applicant has to declare the source of the genetic 
resource (and/or of the ATK) (Art. 49a Patent Law).20 
For research not leading to a commercial product, notifica-
tion to the FOEN is voluntary. 
20 Federal Act on Patents for Inventions of 25 June 1954, classified compilation 232.14. 
www.admin.ch/opc/en/classified-compilation/19540108/index.html
 –  Document your access procedure and store the documentation. 
In case of transfer of material to a third person/entity, hand over 
all corresponding documentation, even if there is no Due Dili-
gence obligation for the accessed resources. 
 – The precise information that needs to be recorded, stored, 
passed on to subsequent users and, if a commercialization is 
involved, also included in a notification to the FOEN, is defined in 
Art. 3 and 4 of the Nagoya-Ordinance.21 
 – Comply with the Due Diligence obligation, although the authori-
ties will verify compliance with Due Diligence by basic research 
only sporadically. Correct ABS documentation will be crucial in 
cases when research on genetic resources turns out to be of 
commercial interest. 
 
Access to Genetic Resources located in Switzerland 
For access to genetic resources located in Switzerland 
no PIC and MAT is required. But all Swiss and foreign 
researchers are obliged to document access as follows: 
 –  Name and address of the user, description of the genetic 
resources and their utilization, date and location of 
access. If a resource is acquired through a third person, 
document the name and address of this person and the 
date of acquisition have to be documented. 
 –  If a genetic resource accessed in Switzerland is trans-
ferred to another user, the first user has to document 
name and address of this person and the date of the 
transfer. 
This information has to be notified to the FOEN before mar-
ket authorization has been obtained or, if such authoriza-
tion is not required, before the commercialization of a prod-
uct developed on the basis of a utilized genetic resource 
accessed in Switzerland (Art. 8 para 3 Nagoya-Ordinance).
A voluntary notification of the research is possible. 
21 For details, see Art. 3 of the Nagoya Ordinance at  
www.admin.ch/opc/de/classified-compilation/20150120/index.html 
Useful Tip
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3.2 Implementation of the International   
 Treaty on Plant Genetic Resources  
 for Food and Agriculture 
Switzerland has implemented the International Treaty in 
its Law on Agriculture22 (Arts. 147a and 147b) and the Ordi-
nance on the Conservation and Sustainable Use of Plant 
Genetic Resources for Food and Agriculture23 (entry into 
force on 1 January 2016). 
According to this ordinance, material of the collections 
(e.g. Agroscope Changins-Wädenswil24) being part of the 
National Gene bank  is available for research for food and 
agriculture, as well as for breeding and development and 
the creation of propagating stock. Access to plant genetic 
material is provided after the user signs the Standard Mate-
rial Transfer Agreement (SMTA) of the Multilateral System 
of the International Treaty. If the material is to be used for 
other purposes, a specific agreement has to be concluded 
between the user and the Federal Office of Agriculture. This 
means that access to all material contained in the National 
Gene bank for non-commercial, academic research for food 
and agriculture is quite straightforward. Benefits are shared 
through results of the research (by publication) (see chapter 
5.5) 
22 Bundesgesetz über die Landwirtschaft vom 29. April 1998, SR 910.1.  
www.admin.ch/opc/de/classified-compilation/19983407/index.html
23 Verordnung über die Erhaltung und nachhaltige Nutzung von pflanzengenetischen 
Ressourcen für Ernährung und Landwirtschaft vom 28. Oktober 2015, SR 916.181.  
www.admin.ch/opc/de/classified-compilation/20151992/index.html
24 www.agroscope.admin.ch/aktuell/00198/00199/04681/index.html?lang=en
4 Case Studies
This chapter presents cases to exemplify various types of 
research and possible ABS procedures. They have been 
selected according to the types of genetic resource and 
utilization. The exemplified types of research are Botany, 
Ecology, Agriculture, Medicine and Ethnobotany, includ-
ing Associated Traditional Knowledge.
Note that the conditions for access are defined by the pro-
vider country, so details of the access procedure will vary 
from country to country. 
4.1 Botany: Inventory of flora and vegetation  
 in a tropical region
The project will conduct inventories of the flora and vege-
tation in an area of the tropics where botany has not previ-
ously been studied in detail. The objective is to prioritize 
areas for conservation and to reach a better understanding 
of the area’s phytogeography. The work will include the 
following steps: in-situ collection of wild plant material; 
preparation of dried herbarium specimens; taxonomic 
identification of plants using reference herbarium speci-
mens and molecular techniques; the sending of collected 
plant material to specialists in different countries for the 
purpose of identification. It is expected that several new 
species will be discovered.
This species-level work will yield a floristic inventory of 
the analysed region. Surveys of vegetation will be con-
ducted in the field and will include analysis of satellite 
images. Vegetation maps will be drawn using Geographic 
Information System technology. A distribution analysis of 
target taxa will also be carried out. In accordance with gen-
eral practice, it was agreed to deposit identified duplicate 
samples in a herbarium of the country in which the plant 
collection occurs.
 Switzerland 
has included all 
material of 
the National 
Gene bank in 
the  Multilateral 
 System of the 
 International 
Treaty
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Genetic resource Wild plant material 
Access In-situ collection 
Utilization Taxonomic identification of plants using morpho-
logical-anatomical characterization and molecular 
techniques, including DNA-Barcoding. It includes 
sending in-situ collected material to taxonomy 
specialists in other countries.
Stakeholders 
involved in 
ABS-procedures
Research institution in user country and the Compe-
tent National  Authority in the provider country
Steps Apply for PIC; negotiate MAT. Inquire about export 
permits. 
Notes MAT: record in writing that the plant material will be 
sent to specialists for taxonomic identification. 
Transfer the plant material with a Material Transfer 
Agreement (MTA) and under the same conditions as 
the Mutually Agreed Terms (MAT) negotiated with 
the provider country. 
4.2 Ecology: Experiment on tree species   
 diversity in a tropical forest 
Logged Dipterocarp forests are being replanted with three 
levels of tree species diversity for the purpose of investi-
gating how forest diversity affects wood production, car-
bon storage and other ecosystem processes in tropical 
regions. The replanting is being carried out using monocul-
tures, low-diversity mixtures similar to those in commer-
cial reforestation areas and using a full mixture of species 
reflecting the natural diversity of the primary forest.
The aim of the project is to compare community and eco-
system processes in low and in high species diversity plots. 
The focus of the analysis is on diversity and wood produc-
tion (carbon sequestration), biogeochemical and hydrolog-
ical variables, and levels of biodiversity. The field research 
is being carried out at a state-owned research station of the 
provider country. Samples of tree litter will be collected 
for biomass quantification. No material, only data, are 
exported to Switzerland. 
Genetic resource Tree litter (leaves and twigs)
Access In-situ collection of plant material 
Utilization Weighing of plant biomass, spherical densiometer 
measurements of canopy coverage. 
Stakeholders 
involved in 
ABS-procedures
(no ABS case) 
Steps Inquire about necessary research permits, export 
permits. 
Notes This research project doesn’t involve molecular 
or biochemical analyses of genetic resources and, 
therefore, it doesn’t fall under ABS regulations of 
the NP. However, check the ABS requirements of 
the provider country. 
4.3 Agriculture: Isolation and assessment  
 of local mycorrhizal fungi  
 for the improvement of yam growth
Yam is the second most important tuber crop in West 
Africa. Annual demand is constantly increasing, while 
annual production per hectare has declined considerably. 
This is mainly due to the prevalence of pests and diseases. 
Arbuscular mycorrhizal fungi (AMF) have been shown to 
act as antagonists to pests (e.g. nematodes) and diseases. 
They also increase the efficiency of soil nutrient uptake and 
water use, particularly in suboptimal soil conditions, and 
thus help to increase crop yield.
As a novel approach to protect yam seed material against 
pathogens, the proposed project assesses the occurrence 
and diversity of AMF in two African countries. 
Soil samples that include arbuscular mycorrhizal fungal 
communities will be collected jointly by Swiss research-
ers and researchers from the provider country. The mate-
rial will be used to analyse soil chemical parameters (pH, 
organic carbon, and phosphate content). Also, AMF spores 
will be isolated and identified. Isolated AMF species will 
be grown together with yam plants in single pots. 
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The screening of AMF isolated for their potential to 
improve yam growth will be carried out in collaboration 
with the International Institute of Tropical Agriculture 
(IITA) in Benin. Techniques include soil sieving to collect 
fungi spores, species identification based on morphological 
characterization and molecular polymerase chain reaction 
(PCR). Part of the screening will be carried out in Switzer-
land. AMF cultures will be sent to IITA for future uses.
Genetic resource Arbuscular mycorrhizal fungi (AMF)
Access In-situ collection of soil samples
Utilization Isolation and screening of AMF. This includes soil 
sieving to collect fungi spores, species identification 
based on morphology and molecular PCR. Cultiva-
tion of yam plants in pots together with AMF.
Stakeholders 
involved in 
ABS-procedures
Swiss Research Institute and Competent National 
Authorities of the two provider countries.
The involvement of the research institute of the pro-
vider country in the ABS negotiations depends on 
the national regulation of the provider country. 
Steps Apply for PIC and negotiate MAT for the research 
on the AMF; inquire for conditions of the IITA for 
utilizing yam tubers. 
Notes Yam is a PGRFA. Therefore, access to the tubers 
falls under the International Treaty. It is included in 
Annex I of the International Treaty. Yet, access in-si-
tu of Annex I varieties is defined by the provider 
country. 
4.4 Agriculture: Growth and bioactives  
 of native potatoes under drought stress
Decreased water availability under the scenario of cli-
mate change will have a significant impact on potato tuber 
yield, growth and quality. In contrast to commercial pota-
toes, native potatoes in general have higher tolerance to 
drought stress, contain higher levels of bio actives (e.g. 
antioxidants, polyphenols, carotenoids, anthocyanins) 
and display a wider range of key nutritional compounds 
(e.g. starch, proteins). Taking into account the ever-increas-
ing importance of potatoes in the agro food industry, this 
project offers an excellent opportunity to bring scientific 
research into practical applications. The project aims at 
(1) assessing the effect of drought stress on tuber induction 
and growth dynamics in native potatoes by means of com-
puted tomography; (2) quantifying changes in phytochem-
icals (bioactives) and key nutritional compounds of native 
potato tubers under drought stress.
Genetic resource 17 native (South American) genotypes of potato 
(Solanum tuberosum)
Access Ex-situ: The material is provided by the Genebank 
IPK Gatersleben, (Leibniz Institut für Pflanzengene-
tik und Kulturpflanzenforschung) Germany.
Utilization Analysis of tolerance to environmental stress, 
plant physiology and assessment of bioactive and 
overall nutritional content in potato tubers.
Stakeholders 
involved in 
ABS-procedures 
and steps
Standard Material Transfer Agreement (SMTA) 
signed by user on behalf of collection 
Notes Potato (Solanum tuberosum) is listed in Annex 1 of 
the International Treaty. Germany is party to this 
Treaty; IPK Gatersleben is a public gene bank and, 
accordingly, the potato samples are accessible 
through the Multilateral System. 
If – in contrast – the user accesses the potato ge-
netic resources on the private field of a farmer, the 
national regulation of the provider country applies. 
The user may have to comply with national ABS 
legislation/regulatory requirements. 
4.5 Medicine: Evolution and epidemiology  
 of tuberculosis 
Tuberculosis (TB) causes many deaths and is rapidly 
increasing in sub-Saharan African countries. The aim of 
this project is to identify population-based clinical and 
molecular determinants of tuberculosis epidemiology and 
ascertain new evidence of the evolutionary pathway of TB 
in humans and livestock. 
The project will establish a molecular characterization 
and clustering of TB strains in relation to prevalence, ani-
mal-human transmission and resistance to antibiotics. 
Repeated observational field studies will be conducted 
in close collaboration with the national tuberculosis pro-
gramme in an African country. Tuberculosis patients will 
be offered treatment within the framework of national 
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tuberculosis programmes. Livestock carcasses will be col-
lected in abattoir surveys for the cultivation of Mycobac-
terium tuberculosis complex. Region-deletion polymerase 
chain reaction and sequencing of single-nucleotide poly-
morphism of genes responsible for antibiotic resistance of 
all isolated TB strains will provide specific information on 
the evolutionary pathways of TB at the interface between 
humans and live-stock and between West and East Africa.
Genetic resource Mycobacterium tuberculosis complex:  
M. tuberculosis, M. bovis
Access In-situ: Livestock carcasses containing 
 Mycobacterium sp. Collecting of bacteria  
in carcasses and in humans.
Utilization Isolation and cultivation of Mycobacterium 
 tuberculosis; identification of strains with 
region-deletion polymerase chain reaction, and 
sequencing of single-nucleotide polymorphism.
Stakeholders 
involved in 
ABS-procedures
Research institute and Competent National 
Authority.
Steps Apply for PIC and negotiate MAT for access to the 
micro-organisms. 
Notes Only microbial genetic resources are accessed. 
 Human genetic resources are not included in  
the CBD. 
4.6 Ethnobotany: Ecological impact  
 of repeated harvesting of wild plants 
The project focuses on the mutual influence of biological 
diversity and local indigenous cultural diversity in a bio-
diversity hotspot in Asia. Five ethnic groups in a remote 
mountain region will be examined as part of a comparative 
ethnobotanical survey. The researchers will investigate the 
differences in plant use and study plant resource manage-
ment of cultivated and collected wild species among the 
ethnic communities. The main question to be addressed 
is whether plant use is influenced by the accessibility of 
certain species or by the traditional culture of an ethnic 
group. The ecological impact of repeated harvesting of wild 
plants on different habitats will be analysed (sustainability 
of use). 
Field work will involve interviews about medicinal plant 
use, the assessment of plant diversity around the villages, 
identification of different plant taxa and the impact of 
repeated plant harvesting. The work will include in-situ 
collection of wild plant material and taxonomic identifica-
tion of plants using reference herbaria. Modern inventory 
techniques relating to plant diversity will be applied. Cur-
rent statistical software tools will be used for the analysis 
of the semi-structured interviews and participatory obser-
vation data.
Genetic resource Wild plant material 
Associated Tradi-
tional Knowledge
Knowledge of indigenous and local communities 
about their use of the plants 
Access Interviews with members of the indigenous and 
local communities about plant use. In-situ  
collection of plants
Utilization Taxonomic identification of plants, analysis of 
interviews and publication of results
Stakeholders 
involved in 
ABS-procedures
Research institute, local communities and 
 Competent National Authority
Steps Apply for PIC of the provider country; inquire 
with the National Focal Point about conditions for 
access to Associated Traditional Knowledge; follow 
instructions to get PIC and MAT of the indigenous 
and local communities; negotiate MAT with the 
provider country. 
Notes The term “traditional knowledge associated with 
genetic resources” is not clearly defined. Here, we 
assume that it is knowledge about the traditional 
use of plants. Accordingly, location of plants, 
harvesting methods and frequency do not fall 
under the term. 
This would need to be verified with the Competent 
National Authority.
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Examples of national ABS regulations 
Provider countries have sovereign rights over their genetic resources 
and, accordingly, national regulations have their singularities. Some of 
them are exemplified below. In any case, users must adhere to the 
national regulations of the provider country. 
In certain countries:
 – Access for certain types of basic research do not fall under ABS. 
 – No PIC and MAT is needed for access to the genetic resources. 
 –  Cooperation with a research institution in the provider country  
is a precondition for applying for PIC and MAT. 
 – When issuing PIC, the Competent National Authority can set the 
prerequisite that a (specific) national institution in the provider 
country is involved in the research project. 
 –  PIC will be granted solely to national (research) institutes in the 
provider country, which have to apply for PIC directly. 
 – PIC and MAT have to be negotiated by the user’s research 
 insti tution and not by an individual researcher.
 – Individual researchers can apply for access but only with a letter 
of guarantee from the Competent National Authority of their 
home country. 
 –  Researchers have the obligation to apply for PIC and MAT for  
access to genetic resources and ATK in their own country. 
 –  Only researchers from a foreign country need apply for PIC and 
MAT. 
5 In-depth information on ABS
5.1 The rationale of ABS 
Global biodiversity is not evenly distributed over the 
planet, a fact that is essential to Access and Benefit-sharing. 
An important part of the global biological diversity occurs 
in the “countries of the South” where genetic and biochem-
ical compounds found in nature are sought for industrial 
research. They serve as a basis for research potentially lead-
ing to marketable products such as pharmaceuticals, cos-
metics and nutritional supplements. The richness in diver-
sity of living species is also of great interest for research and 
education in the academic world that contributes essential 
information for the conservation of biodiversity and its sus-
tainable use.
The problem is that the means and technology needed for 
studying and for adding value to the genetic resources are 
also unevenly distributed over the globe. Many biodiver-
sity-rich countries lack the technological and economic 
means to profitably and sustainably exploit their riches, 
yet are nevertheless responsible for their conservation and 
sustainable use. 
Responsibility for conservation and sustainable use is given to the 
states on whose territory the biological material is located. How-
ever, the entire global community of states has the responsibility 
to cooperate to this end. For the industrialized countries this means 
supporting the biodiversity-rich but often economically-poor coun-
tries in the endeavour. The keywords in this context are technology 
transfer and cooperative research. The CBD contains rules that clar-
ify the rights and responsibilities of all parties involved. 
This scenario of inequality has been aggravated by cases 
where researchers from both academia and industry have 
collected, exported and developed genetic resources with-
out the consent of the countries that provided them, and 
without sharing resulting benefits. This has led to distrust 
and misgivings vis-à-vis each form of research and to accu-
In the CBD, 
 biodiversity-rich 
and  
technology-rich 
countries have 
joined forces for 
conservation and 
sustainable use 
of biodiversity 
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sations of “biopiracy” from biodiversity-rich countries. It 
has been particularly egregious where genetic resources 
were commercially used for products that were patented 
and profitably marketed without consent of the countries 
where they were accessed. 
It is at this point that the CBD and its system on ABS come 
into play. By providing a framework for access and utiliza-
tion of genetic resources and the sharing of benefits arising 
from their utilization (Art. 15 CBD), it combines the aim of 
maintaining and conserving biological diversity with eco-
nomic objectives. Concurrently, it strives to create a bal-
ance between the interests of the biodiversity-rich and the 
technology-rich countries. 
ABS must be seen against the background of sovereign 
rights of states over their natural resources, which is con-
firmed in the CBD. Accordingly, the ABS article of the CBD 
(Art. 15) establishes that States providing genetic resources 
have the authority to determine access to their biological 
resources. This competency of the provider state is coun-
terbalanced by its obligation to create conditions to facili-
tate access by potential users.
The objectives and rules of the CBD and the Nagoya Pro-
tocol apply to accessing and utilizing genetic resources 
in both commercial contexts and academic research. The 
focus in this manual is on academic research. 
Through the CBD its Parties have explicitly attributed value to the 
genetic and biochemical components of biodiversity. The utilization 
of these components for research or for the development of a com-
mercial product is now linked to a permit to access the biological 
material and to sharing the resulting monetary profits or non-mon-
etary advantages. 
5.2 The responsibility of academic  
 researchers 
Academic research – including basic research – is an impor-
tant stakeholder in the ABS scenario. It not only generates 
relevant new knowledge for conservation and sustaina-
ble use of biological diversity, but also a series of benefits 
for academic researchers themselves, including scientific 
experience, knowledge and enhanced professional careers. 
Likewise, academic research generates non-monetary ben-
efits such as education, training, capacity-building, tech-
nology transfer and, not least, collaborative research for the 
provider countries.
Research in a commercial context frequently builds upon 
results of basic academic research on organisms collected 
abroad. Therefore, it is essential that the genetic resources 
are well documented with regard to ABS, in order to provide 
needed information to potential future users. When transfer-
ring genetic resources to third persons or to storage, researchers 
are responsible for the transfer of all relevant documentation. 
Solid partnerships with research institutions and local partners 
from provider countries are not only a way of sharing the benefits 
of academic research, but also provide support for complying to the 
ABS requirements of the provider country. 
Appendix III contains a list of non-monetary benefits resulting from 
academic research. 
5.3 Key terms: Genetic Resources, Access   
 and Utilization and Benefit-sharing 
The term genetic resources in the CBD is closely linked to 
the “genetic revolution” in the second half of the 20th cen-
tury that brought new insights to the inherent potential of 
material contained in all organisms. Advances in science 
have opened new avenues that use genetic information to 
develop a wide range of products and services in many sec-
The objective: 
 cooperation 
 between provider 
and user of 
a genetic 
 resource
Useful tip
It is a give-and-
take to facilitate 
access and 
equitably share 
benefits
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tors, e.g. agriculture, pharmaceuticals, cosmetics, environ-
mental services and techniques. 
It is in this broad sense that the CBD defines genetic resources 
as genetic material, i.e. material containing functional units 
of heredity that is of actual or potential value (CBD Art. 
2.10). According to the Nagoya Protocol, biochemical com-
pounds contained in organisms are subsumed under this 
term even if they don’t contain functional units of heredity. 
As the CBD definition also includes the potential value of 
such resources, almost all biological material falls under 
the provisions of the ABS system. 
The ABS system covers all types of genetic resources, wild or 
domesticated, of animal, plant, microbial or other origin, located 
on private or public land or waters within the territories of CBD 
Parties. ABS obligations apply to research on resources that are 
located and collected in-situ or procured from ex-situ facilities or 
from academic partners. Excluded from the scope of application of 
the CBD are human genetic resources. 
The term “access” is not defined in the CBD or in the Nagoya 
Protocol. Thus, its meaning depends on the interpreta-
tion of each provider country. The Nagoya Protocol, in its 
Art. 6, links “access to genetic resources” to the PIC of the 
provider country, and sets “utilization of genetic resources” as 
the trigger for the benefit-sharing obligation. Utilization of 
genetic resources means to “conduct research and devel-
opment on the genetic and/or biochemical composition of 
genetic resources, (Art. 2(c) NP). “Research and development” 
is not defined in the Nagoya Protocol. It includes all types 
of research in academic and commercial contexts: basic 
research as well as research and development aimed at new 
and potentially profitable products or procedures. 
Plant Genetic Resources for Food and Agriculture (PGFRA) are 
defined as any genetic material of plant origin of actual or 
potential value for food and agriculture. The term “genetic 
material” includes reproductive and vegetative propagat-
ing material containing functional units of heredity (Art. 2 
International Treaty). National legislation may define in 
more detail which resources are subject to the Interna-
tional Treaty (e.g. wild relatives of domesticated varieties 
or medicinal plants). 
The requirement to share fairly and equitably the benefits result-
ing from the utilization of genetic resources and/or associated tra-
ditional knowledge sets out from the premise that every uti-
lization of genetic resources and/or associated traditional 
knowledge in the sense of the CBD and the Nagoya Protocol 
generates economic or non-economic values. Principles of 
equity demand that these values are shared in a fair way 
with the custodians of the underlying biological diversity 
and traditional knowledge. 
5.4 International legal framework
The international legal framework of ABS consists in the 
CBD (primarily its Article 15), the Bonn Guidelines on 
Access and Benefit Sharing (Bonn Guidelines) and the 
Nagoya Protocol, as well as the International Treaty on 
Plant Genetic Resources for Food and Agriculture. 
The CBD and the Nagoya Protocol 
The mechanism linking access to genetic resources to the 
sharing of benefits resulting from their utilization has been 
first laid down in the CBD. However, Art. 15 of the CBD only 
includes the basic principles of ABS. In order to facilitate 
the implementation of the ABS system in the Parties, the 
Bonn Guidelines (BGL) were elaborated and adopted by the 
Conference of the Parties to the CBD in 2002. The BGL are 
voluntary and intended to guide both providers and users 
of genetic resources in the implementation of ABS. They 
are a useful source to help understand the mechanism. 
In 2010 the Nagoya Protocol was adopted by the parties to 
the CBD. It entered into force on 12 October 2014. To date 
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(July 2016) it has been ratified by 74 States;25 Switzerland 
is among them. 
The Nagoya Protocol substantiates the CBD’s ABS provi-
sions. It aims at providing greater legal certainty and trans-
parency for both providers and users of genetic resources. 
It sets out core obligations for its Contracting Parties to take 
measures in relation to access to genetic resources, bene-
fit-sharing and compliance. It defines roles and responsi-
bilities of the providers and users of genetic resources and 
includes measures to facilitate access and to promote com-
pliance. How Parties implement the system at the national 
level depends on the political decision of each individual 
Party. 
The Nagoya Protocol also applies to academic research. 
The Nagoya Protocol explicitly recognizes the importance 
of research for conservation and sustainable use of biologi-
cal diversity. Parties should, therefore, create conditions to 
promote this type of research, including simplified meas-
ures with regard to access for non-commercial purposes. 
The Nagoya Protocol specifies that if facilitated access for 
research is granted, the possibility of a “change of intent” 
needs to be addressed (Art. 8 [a] NP). For example, a change 
of intent occurs with the transition of a resource from the 
academic to the commercial field. 
The ABS system is also applicable to the Traditional Knowl-
edge of Indigenous and Local Communities Associated with Genetic 
Resources (Associated Traditional Knowledge). If research 
involves Associated Traditional Knowledge, indigenous 
and local communities are to be involved in the ABS pro-
cedures. 
The obligations of the Nagoya Protocol are applicable to genetic 
resources and associated traditional knowledge that have been 
accessed in-situ after its entry into force on 12 October 2014.26 
25 Update available on the ABS Clearing House (absch.cba.int)
26 The interpretation of the temporal scope is still under discussion among  
the parties to the Nagoya Protocol.
For parties to the CBD that have not (yet) ratified the Nagoya Proto-
col, only the basic obligations of the CBD are applicable. Research-
ers who access resources in these countries must comply with 
their national legislation or regulatory requirements but are not 
subject to the Swiss ABS legislation. 
 
The International Treaty on Plant Genetic Resources  
for Food and Agriculture 
The International Treaty applies the principles of access 
and benefit-sharing to plant genetic resources for food and 
agriculture. 
Agricultural crop-breeding depends on easy access to and 
exchange of crop varieties. The implementation of the 
full bilateral ABS system of the CBD would hamper plant 
breeding. Therefore, in the International Treaty on PGRFA 
the Multilateral System of Access and Benefit Sharing 
(Multilateral System) was negotiated to facilitate access 
and benefit-sharing to a series of the most important vari-
eties of crops. 
The goal was to create a system that is efficient, effective 
and transparent. The Multilateral System offers a standard-
ised procedure for access to the PGRFA and the sharing of 
benefits resulting from their utilization.
The Multilateral System establishes a global approach of 
granting everyone access to the genetic resources of (at 
least) 64 crop and forage species that are selected accord-
ing to their importance for food security and their interde-
pendence. It also aims to ensure the fair and equitable shar-
ing of benefits arising from the utilization of these genetic 
resources in order to promote conservation, sustainable use 
and further development of agriculture (in the developing 
world). The crops are listed in Annex I of the International 
Treaty.27 For specified utilizations – conservation, research 
and breeding – users of genetic resources simply sign the 
International Treaty’s Standard Material Transfer Agree-
27  www.planttreaty.org/content/crops-and-forages-annex-1 
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ment (SMTA) issued by a gene bank that participates in 
the system. Accordingly, there is no need to either verify 
legitimate access of the gene bank, to track the origin of the 
accessions or to negotiate individual agreements. 
In terms of benefits, the user agrees to share the results of 
his research/breeding. If the user develops a commercial 
product and concurrently limits access to the product (by 
intellectual property rights), a percentage of the commercial 
product profit must be paid into a common funding pool.
The Multilateral System consists of collections that include 
varieties 
 –  that are under the control and management  
of governments of the contracting parties; 
 –  that belong to private or legal persons that have been 
voluntarily included in the system; 
 –  that are stored in the International Agriculture Research 
Centres (IARCs) of the Consultative Group  
on International Agricultural Research (CGIAR). 
Non-Annex I varieties can be included voluntarily into the 
Multilateral System by the contracting parties, for instance 
Switzerland has done this. 
For information on which set of international rules applies 
to your research, see Tables II and III in chapter 2.4. 
In the following cases, access to PGRFA is subject to the ABS legisla-
tion/regulation of the provider country: 
 –  Access in-situ;
 – Access ex-situ to varieties that are not listed in Annex I  
of the International Treaty (and not included in the Multilateral 
System by the provider country);
 –  Access ex-situ in countries that are not party  
to the International Treaty
 –  Access ex-situ to all varieties in collections that are  
not included in the Multilateral System. 
Useful sources for access to PGRFA
 – Parties to the International-Treaty: 
www.planttreaty.org/list_of_countries
 – National Focal Points: www.planttreaty.org/nfp
 – Collections included in the Multilateral System: 
www.planttreaty.org/inclusions 
5.5 Associated Traditional Knowledge 
Traditional Knowledge Associated to Genetic  Resources
The CBD and the Nagoya Protocol do not provide a defi-
nition of the term “Traditional Knowledge Associated to 
Genetic Resources”. It is left to the parties to define thze 
term in their implementing measures. The following defini-
tion is adapted from the definition used in the discussions 
of the World’s Intellectual Property Organization (WIPO) 
Intergovernmental Committee on Intellectual Property and 
Genetic Resources, Traditional Knowledge and Folklore:
Associated Traditional Knowledge is knowledge resulting from 
intellectual activity in a traditional context that is specific or gene-
 ral in its relationship to genetic resources. It includes know-how, 
practices, skills and innovations. It can be found in a wide varie ty 
of contexts, including: agricultural knowledge; scientific knowl- 
edge, technical knowledge, ecological knowledge, medicinal knowl-
edge, including related medicines and remedies; and biodiversity- 
related knowledge. 
www.wipo.int/tk/en/resources/glossary.html#50
 
Access to Associated Traditional Knowledge
According to the Nagoya Protocol, details of the procedure 
for access to Associated Traditional Knowledge have to be 
determined by the countries that are Party to the Nagoya 
Protocol, within the borders of which the indigenous and 
local communities are located. The countries are to ensure 
that Associated Traditional Knowledge held by indigenous 
and local communities is accessed with PIC or approval and 
involvement of the communities, and that MAT are nego-
Useful tips
The Multilateral 
System of 
the International 
Treaty offers a 
standardized 
system for access 
to PGRFA and 
benefit-sharing
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tiated. They also must establish mechanisms and instru-
ments to inform potential users of Associated Traditional 
Knowledge about their obligations. In some countries, gov-
ernments are working together with the communities to set 
up the respective systems and procedures. 
In the CBD this principle is less clear. But also in countries 
that are only Party to the CBD, ABS with regard to associ-
ated traditional knowledge depends on the national legisla-
tion/regulation of the country where the associated traditional 
knowledge provider is located.
1. Associated Traditional Knowledge can only be accessed with PIC 
or approval and participation of the involved indigenous and 
local communities. MAT must also be established. 
2. Respective steps and procedures are fixed in the legislation/reg-
ulation of the provider country. 
3. The provider country, the ABS Focal Point and/or Competent 
National Authority must supply information to potential users.
The same principles apply in cases where communities have 
an established right to grant access to the genetic resources 
situated on their territory (Art. 6.2. Nagoya Protocol). 
Ongoing international developments 
In two international organizations there are ongoing par-
ticipatory processes to implement the CBDs/NPs rules on 
access to Associated Traditional Knowledge. 
In 1998, the Conference of the Parties to the CBD appointed 
the Ad-hoc Working Group on the implementation of Art. 8(j) (of the 
CBD)28 on traditional knowledge of indigenous and local communi-
ties.29 At present, this working group is developing guide-
lines that include assisting Contracting Parties in creating 
mechanisms to ensure 1) that indigenous and local commu-
28 This article introduces the basic elements of ABS to ATK. 
29 Ad Hoc Open-ended Inter-sessional Working Group to address the implementation 
of Article 8 (j) and related provisions; www.cbd.int/traditional/intro.shtml.  
Cf Decision IV/9 of the Conference of the Parties, 
 www.cbd.int/decision/cop/default.shtml?id=7132.
nities obtain a fair and equitable share of benefits; 2) that 
entities interested in using Associated Traditional Knowl-
edge obtain the PIC of the indigenous and local communi-
ties.30 The World Organization on Intellectual Property – in its IGC31 
– “is undertaking text-based negotiations with the objective 
of reaching agreement on (a) text(s) of an international legal 
instrument(s), which will ensure the effective protection 
of traditional knowledge (TK), traditional cultural expres-
sions (TCEs) and genetic resources (GRs)”.32
5.6 Elements of the ABS procedure:  
 Authorities and instruments 
According to the Nagoya Protocol, countries as providers 
are free to decide whether they want to control access to 
and utilization of the genetic resources on their territory. 
Also it is in the discretion of the Parties to decide on the 
details of the procedures for access to genetic resources and 
Associated Traditional Knowledge.
The CBD, in its Art. 15, spells out the basic elements of the 
ABS procedure: Prior Informed Consent, Mutually Agreed 
Terms, and Fair and Equitable Sharing of Benefits arising 
out of the utilization of genetic resources. 
The Nagoya Protocol, in order to enhance efficacy and trans-
parency of the ABS procedures and to facilitate the monitor-
ing of the utilization of the resource, clarifies and specifies 
the procedural requirements and proposes an institutional 
structure for the Parties: National Focal Points, Competent 
Authorities and Checkpoints. On the international level it 
establishes the ABS Clearing House and – in order to facil-
30 For the respective draft guidelines, see the Annex of Recommentdation 9/1. 
Adopted by the Working Group on 7 November 2015, UNEP/CBD/WG8J/REC/9/1, 
accessible at www.cbd.int/recommendations/wg8j/?m=wg8j-09; CBD programme 
of work on the implementation of Art. 8(j) and related provisions of the Convention 
on Biological Diversity; accessible at www.cbd.int/traditional/pow.shtml; 
31 Intergovernmental Committee on Intellectual Property and Genetic Resources, 
Traditional Knowledge and Folklore
32 www.wipo.int/tk/en/ 
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itate the administrative burden for users – provides for an 
Internationally Recognized Certificate of Compliance. 
 
Prior informed consent, Mutually Agreed Terms  
and the Sharing of Benefits 
Prior Informed Consent is a unilateral declaration of the 
authority defined by the national legislation/regulation of 
the provider country. In many cases this will be the Com-
petent National Authority. 
PIC means, in principle, that the provider country has been 
informed of the planned research as part of the application 
process and that it gives its consent prior to the start of the 
research. 
The prior informed consent is a prerequisite for access to 
biological resources. In many cases, the required informa-
tion and the procedure are specified in national regulations. 
Under national regulation it may also be necessary to include 
stakeholders involved at various intermediary levels in the 
PIC process, especially if your research involves ATK. 
According to the Nagoya Protocol, the National Focal 
Points are to provide information on procedures for PIC 
and MAT, including procedures of access to ATK, and on 
addressing competent national authorities and other rele-
vant stakeholders (Art. 13.1 NP). 
Mutually Agreed Terms are a contract negotiated between the 
users and providers of genetic resources. This contract 
defines the conditions for access to genetic resources and 
grants permission for their utilization. And, crucially, it 
incorporates an agreement on how to share the benefits aris-
ing from the utilization of the genetic resources. The regu-
latory requirements of the provider country and the com-
plexity of the proposed research influence the elements of 
MAT. Countries may have official standard formats for the 
MAT. The Swiss Academy of Sciences offers a MAT tool-
kit for non-commercial academic research that is meant to 
serve as a template that can be applied to fill the gap where 
no national tools are available (s. Chapter 2.1).33 
The fair and equitable sharing of benefits arising from the utiliza-
tion of genetic resources and/or Associated Traditional Knowledge 
is one of the main rationales of ABS. The CBD, in its Art. 
15.7., explicitly spells out that this includes “sharing … the 
results of research and development and the benefits aris-
ing from the commercial and other utilization of genetic 
resources…”. Accordingly, the principle of fair and equi-
table sharing of benefits extends to academic research. 
Although this type of research yields benefits that are 
non-monetary as a rule, they nevertheless are of value to 
the provider country, particularly for conservation and sus-
tainable use of biological diversity. Academic research ben-
efits include the research results, education and capacity 
building, technology transfer and the establishment of per-
manent academic networks and cooperation (see Appendix 
III). With these tools, science and research can help bridge 
the North-South divide through the transfer of urgently 
needed knowledge and technology. 
 
Responsible public agencies on national level: National Focal 
Point; Competent National Authorities and Checkpoints 
The National Focal Points are the first contact point for research-
ers or other applicants seeking access to genetic resources 
and/or Associated Traditional Knowledge. They are meant 
to provide information on procedures for obtaining PIC 
and negotiating MAT, including from holders of Associated 
Traditional Knowledge; and to advise how to address the 
authorities, indigenous and local communities and other 
involved stakeholders. Contact information on the National 
Focal Points can be accessed on the ABS Clearing House.34 
The Competent National Authorities are responsible for grant-
ing access and for issuing written evidence that the user has 
33 Accessible at www.naturalsciences.ch/organisations/biodiversity/
 abs/publications
34 absch.cbd.int
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met the access requirements, ideally in the form of an inter-
nationally recognized certificate of compliance. In many 
cases, the Competent National Authorities are the primary 
partners for the negotiation of the MAT. 
Checkpoints
Checkpoints are a means to enhance transparency about the utiliza-
tion of genetic resources and to support compliance. Their task is to 
monitor the utilization of genetic resources. Parties are to designate 
one or several checkpoints. The checkpoints collect or receive rele-
vant information related to (1) prior informed consent, (2) the source 
of the genetic resources, (3) the establishment of mutually agreed 
terms and/or the utilization of genetic resources (NP Art. 17). 
Checkpoints transfer a summary of the information collected or 
received (except confidential information) to the ABS Clearing House 
where it is published (checkpoints communiques). Thus, information 
on the provided genetic resources becomes accessible for the pro-
viders/providing countries. For instance, the Swiss Checkpoint can 
submit selected (non-confidential) information to the ABSCH that it 
receives in connection with the Swiss obligation of notification that 
its users have (see Art. 23o 2 NCHA).
National authorities and their competences, as well as conditions and 
requirements for granting access, are specified in the national law 
and regulations of the provider countries. The National Focal Points 
are meant to provide respective information.
The designation of these administrative structures is not required in 
CBD-only countries! 
 
Assistance to transparency and information flow:  
The ABS Clearing House and the International Recognized 
Certificate of Compliance.
The Access and Benefit-sharing Clearing-house (ABSCH) is an 
internet-based, global information portal and database to 
facilitate access to and exchange of information on ABS. 
It is a key tool for facilitating the implementation of the 
Nagoya Protocol.
The purpose of the ABSCH is to enhance legal certainty and 
transparency on procedures for access, and for monitoring 
the utilization of genetic resources along the value chain. 
It thus builds a bridge between the needs of providers and 
users by supplying relevant information on parties to the 
Convention on Biological Diversity and the Nagoya Proto-
col. 
The ABSCH is established by the Nagoya Protocol (Art. 14) 
and maintained by its international secretariat. The Pro-
tocol identifies the information that Parties either must or 
may submit to the Clearing-House. It provides information 
that is relevant for providers and users of genetic resources 
and Associated Traditional Knowledge:
 
What users seek Information on the ABSCH
Access to GR and ATK
 – A clear understanding of 
how to access
 – Legal certainty for  
utilization of the GR 
and TK
 –  Status (Party to the NP or not)  
of a country 
 –  Contact data of the Focal Point 
and the Competent National 
Authority 
 –  Legislative, administrative or 
policy measures 
 –  National websites and databases 
 –  Internationally Recognized 
 Certificate of Compliance 
Useful tip
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Appendix
I Additional permits for research on Genetic  
 Resources
Research on genetic resources might require additional per-
mits either at the national level from the provider country 
(i.e. research permits, export permits, phytosanitary certif-
icates) or at the international level (permits based on the 
International Convention on the Trade with Endangered 
Species of Wild Fauna and Flora [CITES]). 
National level 
Research permit 
A research permit is a unilateral order from the appropriate 
ministry (e.g. research, education) of the host country. It 
frequently has a standardized form. It might be required in 
addition to the Prior Informed Consent. Researchers should 
inquire whether a specific research permit must be applied 
for. 
If you access resources in a country without ABS legisla-
tion or procedures, legal security is increased if some essen-
tial ABS elements are included in your research permit to 
make it compatible with ABS requirements. To this end it 
is recommended that you indicate benefits to be shared (e.g. 
cooperation with…); include permitted use (e.g. no com-
mercialization) and a clause about intellectual property 
rights (e.g. no patenting of the research results).35 
Export permit
Many countries require permits for the exportation of 
samples of natural resources; there might be a ban on the 
exportation of specific varieties/organisms. If you plan 
35 For more information, see “Agreement on Access and Benefit-sharing for academic 
research Annex IV.  
Accessible at www.naturalsciences.ch/organisations/biodiversity/abs/publications.
What providers want Information on the ABSCH
Monitoring of compliance: 
 –  Control over of GR and 
ATK
 –  Ensure that users com-
ply with MAT
 –  Assurance of entitled 
benefits arising from 
utilization
 –  Checkpoints contact data 
 –  Checkpoint communiques that 
allow the provider to monitor the 
utilization of the resource 
The ABSCH is a/the first point of information when planning research 
on Genetic Resources and/or associated Associated Traditional 
Knowledge in the provider country. 
The Internationally Recognized Certificate of Compliance is meant 
to ease the documentation of the legitimate access to the 
genetic resources and/or Associated Traditional Knowl-
edge throughout the value chain. It is issued by the pro-
vider of the genetic resource and/or Associated Traditional 
Knowledge according to a format defined and registered 
by the ABSCH. The certificate serves as evidence that the 
genetic resource it covers has been accessed in accordance 
with (1) prior informed consent and (2) mutually agreed 
terms have been established. It contains the minimum nec-
essary information to allow the monitoring of the utiliza-
tion of genetic resources through the value chain. 
Useful tip
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to analyse samples in your home institution, at an early 
planning stage inquire about conditions for exportation. 
There are also countries (e.g. Brazil) where the export 
permit is included in the PIC and MAT. 
Phytosanitary Certificate
Plant protection certificates are issued after phytosanitary 
control by official plant protection services of the export-
ing countries in compliance with international standards 
(IPPC-International Plant Protection Convention). In Swit-
zerland, such certificates are required for import/export of 
virtually all the plant material from/to non-EU countries. 
Plant protection certificates for exports are issued by the 
Plant Protection Services of Agroscope and FOEN/WSL 
(Swiss Federal Institute for Forests, Snow and Landscape 
Research).36
International Level
International Convention on the Trade with Endangered Species  
of Wild Fauna and Flora (CITES)
The CITES is a trade agreement. The convention intends to 
ensure that international trade in species at risk is limited 
to the extent permitted by their natural stocks as agreed by 
its over 180 Parties.
Any crossing of national borders by live animals and plants 
and all their parts and products is defined by CITES as trade; 
the CITES obligations are, therefore in most cases, appli-
cable for academic research. A precondition for all CITES 
permits is that the specimens have been legally obtained. 
This includes compliance with the ABS regulatory require-
ments of the provider country. 
There exists an exemption from the CITES permits for 
non-commercial loan, donation or exchange of herbarium 
specimens and for other preserved, dried or embedded 
museum specimens, and live plant material between regis-
36  www.phytosanitarycertificate.ch/?action=page&page=HOME 
tered scientific institutions. No export permit is needed if 
the specimens carry a label issued or approved by a CITES 
Management Authority, and if they are transferred among 
registered scientists or scientific institutions. This implies 
that both the sending and the receiving institutions have 
been registered by their corresponding CITES Management 
Authorities. For registration, these institutions need to meet 
requirements for state-of-the-art collection and curation.37 
Trade in species threatened with extinction (Appendix I) 
is permitted only in exceptional circumstances. Both an 
export permit issued by the CITES Management Author-
ity from the state of export, and an import permit issued 
by the Management Authority from the state of import are 
required. 
Appendix II includes species not necessarily threatened with extinc-
tion, but in which trade must be controlled in order to avoid utili-
zation incompatible with their survival. An export permit or re-ex-
port certificate issued by the Management Authority of the state 
of export or re-export is required and, in most countries, an import 
permit is also required.
A country can ask other CITES signatories for assistance in 
controlling the trade (Appendix III). In this case, an export 
permit issued by the Management Authority of that state, 
a certificate of origin from other states within the range 
of distribution of the species concerned and, in cases of 
re-exports, a CITES re-export certificate are required. Some 
countries also require import permits. 
37 The list of registered institutions is accessible under 
 www.cites.org/eng/common/reg/e_si.html
Under the CITES 
agreement, any 
crossing of 
national borders 
by live animals 
and plants and all 
parts and prod-
ucts are  defined 
as trade; the 
CITES  obligations, 
therefore in most 
cases, apply 
to academic 
research
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II Glossary
38
Term Description 
ABS Clearing-House The term refers to the global information portal that is established by 
the Nagoya Protocol and maintained by its International Secretariat. The 
Protocol identifies information that Parties either must or may submit 
to the Clearing-House. The ABS Clearing-House is an important informa-
tion-hub for ABS (Glossary for Europe28).
Access (to genetic 
resources)
The term “access to genetic resources“ is not defined in the CBD and, 
therefore, varies according to national legislation/regulation and prac-
tices. Researchers must verify with the provider country which of their 
activities are subsumed as access in the national regulations.
Benefit (monetary/ 
non-monetary)
Economic or academic advantages arising from research on/utilization 
of genetic resources and/or Associated Traditional Knowledge  
Benefit-sharing Fund A common fund to support conservation and further development of 
agriculture, particularly in the developing world. The fund is fed by the 
payment of a percentage of benefits resulting from the commerciali-
zation of genetic resources (protected by Intellectual Property Rights) 
under the Multilateral System.
Biochemical compound Biochemically active part of (plant) genetic resources. 
Research on the biochemical composition is included in the term “utili-
zation of genetic resources” that triggers ABS, according to the Nagoya 
Protocol (Art. 2 [c] Nagoya Protocol). 
Biological diversity/ 
Biodiversity
Variability that exists among living organisms from all sources, includ-
ing terrestrial, marine and other aquatic ecosystems and the ecological 
complexes of which they are a part. This includes diversity within 
species, between species and their ecosystems (Art. 2.1 CBD).
Biological material, 
Biological resources
Biological resources include genetic resources, organisms or parts 
thereof, populations, or any other biotic component of ecosystems with 
actual or potential use or value for humanity (Art. 2 CBD).
Change of intent The alteration of intended use of resources accessed under MAT for 
basic research (no commercialization) to that for research and develop-
ment for potential commercial use. In case of such “change of intent,” 
new PIC and MAT of the providers is needed. 
Commercialization Commercialization means to sell products developed on the basis of 
utilised genetic resources or of utilised associated traditional knowl-
edge, as well as other legal transactions in connection with utilised 
genetic resources or with utilised traditional knowledge that result in 
monetary benefits, in particular licences, pledge agreements or similar 
legal transactions (Nagoya-Ordinance, Art. 2e) 
Competent National 
Authority 
Agency in the provider country that is entitled to grant access, namely 
to issue the PIC and to negotiate and conclude the MAT according to its 
national legislation and regulatory requirements 
Contracting Party State that has ratified an international convention and thus has to 
implement its obligations on national level 
38 Glossary for Europe: Glossary of key terms used in the context of “Access and Benefit-sharing” ec.europa.eu/.../
Glossary%20for%20Europa.pdf
Due Diligence According to the Swiss legislation (Art. 23n) due diligence in access and 
utilization of GR requires that resources are accessed lawfully and that 
MAT are established. The exercise of due diligence “appropriate to the 
circumstances” is the responsibility of the user. 
Ex-situ Cf. in-situ 
Genetic resources Genetic materials, i.e. any material of plant, animal, microbial or other 
origin containing functional units of heredity that is of actual or 
 potential value (Art. 2 CBD. The value need not be commercial  
[i.e. monetary]), but may be scientific or academic in nature. 
Genetic resources 
value chain 
The term is used to describe the totality of typical steps taken to create 
environmental, social and economic value from genes and naturally 
occurring bio-chemicals found in nature. The genetic resources value 
chain starts with the collection of some material and possibly ends 
with the successful commercialization of a final product. Typical 
 progression is from the collection of genetic resources, the storage 
of collected material, basic research on genetic resources, applied 
research on genetic resources, the development of products and 
 eventually the commercialization of products. Not all these steps will 
necessarily be taken for each sample collected in the wild. Not all 
collected material is stored in collections. In a few cases, material is 
collected by an agent of a company specifically interested in a sample 
of a known organism. Most basic research will not result in concrete 
applications; much applied research ends without moving to the  
development of a product. Additionally, many development efforts 
never make it to the product approval stage (Glossary for Europe).
Indigenous and local 
communities 
The CBD and the Nagoya Protocol do not define this term. It is left to the 
Parties of the Protocol to define this term in their implementing meas-
ures. In the context of the Nagoya Protocol the term ‘indigenous and 
local communities’ is generally understood to encompass communities 
living close to nature and holding genetic resources and traditional 
knowledge associated with genetic resources (Glossary for Europe). 
In-situ/ex-situ Genetic resources can be wild, domesticated or cultivated. ‘In-situ’ 
genetic resources are those found within ecosystems and natural 
habitats. ‘Ex-situ’ genetic resources are those outside their normal 
ecosystem or habitat, such as in botanical gardens or seed banks, or in 
commercial or university collections (CBD Secretariat Information Kit37). 
International Plant 
Exchange Network 
(IPEN)
IPEN is a voluntary registration system intending to facilitate plant 
exchanges of member botanical gardens in accordance with the CBD 
provisions.
Internationally 
 recognized certificate 
of compliance
A certificate issued by the provider of the genetic resource and/or 
Associated Traditional Knowledge, according to a format defined by the 
ABSCH and registered by the ABSCH. The certificate serves as evidence 
that the genetic resource it covers has been accessed in accordance 
with (1) prior informed consent and that (2) mutually agreed terms have 
been established. It contains the minimum necessary information to 
allow the monitoring of the utilization of genetic resources through the 
value chain.
37 CBD Secretariat InformationKit: Access and benefit-sharing information kit. Introduction to access  
and benefit-sharing, glossary. www.cbd.int/abs/information-kit-en
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III Benefit–sharing in the context  
 of academic, non-commercial research40 
Sharing of Academic benefits
 –  Provide access to scientific data resulting from the 
research, including the necessary infrastructure
 – Provide access to ex-situ facilities
 – Integrate partners into the reviewing process
 – Co-publish research findings with research partners
 – Support the academic careers of research partners
 – Maintain institutional and professional relationships
 
Capacity building, scientific cooperation,  participation, 
 technology transfer
 –  Train local researchers in the field and in the laboratory
 –  Share samples
 –  Secure finance for maintenance of collections
 –  Provide research infrastructure (e.g. laboratory equip-
ment)
 –  Provide communication infrastructure
 –  Integrate local researchers into scientific and practical 
work
 –  Integrate local assistants into practical work
 –  Implement research on a cooperative basis: cooperative 
project design; cooperative project implementation 
 
Increased availability of information and knowledge
 –  Provide ongoing information about research, progress 
and expected results
 –  Inform all involved stakeholders about results in a form 
that is adapted to the target audience
 –  Maintain contact with (local) representatives of 
administration, government agencies and research 
institutes
40  Adapted from the Bonn Guidelines and the Nagoya Protocol. 
Material Transfer 
Agreement (MTA)
Contract that governs the transfer of tangible research materials 
 between two organizations when the recipient intends to use it for 
his or her own research purposes. The MTA defines the rights of 
the provider and the recipient with respect to the materials and any 
derivatives.
Multilateral System of 
ABS (MLS)
The Multilateral System establishes a global approach of simplified 
 access to specified PGRFA and sharing of benefits from their utilization 
in order to promote conservation and sustainable use  
(www.planttreaty.org). 
Mutually Agreed Terms 
(MAT)
An agreement between provider country/provider of genetic resources 
and traditional knowledge and the users, on the conditions of access 
and utilization of the resources, and on the benefits to be shared 
between both parties (CBD Secretariat Information Kit). 
National Focal Point Agency established by the state that provides information on 
 authorities/communities to contact, on conditions for access to genetic 
resources and Associated Traditional Knowledge, and procedures to 
observe. 
Party see Contracting Party
Plant Genetic 
 Resources for Food 
and Agriculture 
(PGRFA)
Any genetic material of plant origin of actual or potential value for food 
and agriculture. “Genetic material” means any material of plant origin, 
including reproductive and vegetative propagating material, containing 
functional units of heredity (Art. 2 International Treaty). 
Prior Informed Consent 
(PIC)
Permission given by the Competent National Authority of a country  
to an individual or institution seeking to obtain access to genetic 
resources, complying with an appropriate legal and institutional 
 framework (CBD Secretariat Information Kit) 
Provider country Party providing genetic resources that is the country of origin of such 
resources or that has acquired the resources in accordance with the 
CBD (Art. 15 CBD, Art. 6 NP) 
Provider Institution that according to the domestic legislation or regulatory 
requirements has the competence to grant access. It may be different 
from the Competent National Authority (institution with delegated 
competence) or act in addition to the Competent National Authority 
(Holders of ATK, decentralised agency). 
Traditional Knowledge 
(associated to genetic 
resources)
Associated Traditional Knowledge is knowledge resulting from 
 intellectual activity in a traditional context that is specific or general in 
its relationship to genetic resources. It includes know-how, practices, 
skills and innovations. It can be found in a wide variety of contexts, 
including: agricultural knowledge; scientific knowledge, technical 
knowledge, ecological knowledge, medicinal knowledge, including 
related medicines and remedies; and biodiversity-related knowledge. 
www.wipo.int/tk/en/resources/glossary.html#50
User of genetic 
 resources
In the academic context, all researchers who access genetic resources 
(cf. above) and/or make use of genetic resources
Utilization of genetic 
resources
To conduct research and development on the genetic and/or 
 biochemical composition of genetic resources, including through the 
application of biotechnology… (Art. 2(c)NP)
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Application, research and development, patenting
 –  Develop research directed at the practical needs and 
problems of the provider country
 –  Promote participation in product development
 –  Establish joint ownership of relevant intellectual 
property rights based on the level of contribution
 –  Share economic benefits (e.g. resulting from license 
fees) 
 – Benefits should be aimed at conservation and the sustainable 
use of biological diversity.
 –  Benefits should be shared fairly and equitably between all those 
who have contributed to the resource management and scien-
tific and/or commercial process.
 –  Differences exist in benefit-sharing options between basic 
research, applied research and research and development for 
commercial uses.
 –  It may be necessary to explain carefully that academic research 
does not lead to economic benefits in most cases.
 –  A large part of the sharing of benefits may have to be carried 
out concurrently with the research itself.
 –  There are benefits that can only be shared once research has 
been accomplished.
IV Links and Sources 
Switzerland
 –  Swiss Federal Office for the Environment (FOEN): 
www.bafu.admin.ch 
 –  FOEN ABS website: 
 ·  e: www.bafu.admin.ch/Nagoyaprotocol 
 · d: www.bafu.admin.ch/NagoyaProtokoll
 · f: www.bafu.admin.ch/protocoleNagoya
 ·  i: www.bafu.admin.ch/protocolloNagoya
 –  Swiss Information System Biodiversity (SIB):  
www.sib.admin.ch/en/index.html
 – Bundesamt für Landwirtschaft (BLW);  
www.blw.admin.ch
 – BLW, International, Agrobiodiversität und genetische 
Ressourcen:  
www.blw.admin.ch/themen/00009/01779/01808/index.
html?lang=de
 – BLW, Agroscope, Schweizer Forschung für Land-
wirtschaft, Ernährung und Umwelt, Pflanzengenetische 
Ressourcen: www.agroscope.ch/ressources- 
phytogenetiques/index.html?lang=de 
 –  Swiss Academy of Sciences (SCNAT), Information on 
ABS for academic research:  
www.naturalsciences.ch/organisations/biodiversity/abs
 –  Swiss Academy of Sciences (SCNAT), Agreement on 
Access and Benefit-sharing for Non-commercial 
Research – Sector specific approach containing Model 
Clauses: 
www.naturalsciences.ch/organisations/biodiversity/
abs/publications 
Convention on Biological Diversity (CBD)
General website: www.cbd.int
CBD text: www.cbd.int/convention/text
Nagoya Protocol, general website: www.cbd.int/abs
Nagoya Protocol, text: www.cbd.int/abs/text/default.shtm
ABS Clearing-House: http://absch.cbd.int 
CBD Secretariat (2011) Access and benefit-sharing 
 information kit: www.cbd.int/abs/information-kit-en 
Useful tips
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International Treaty on Plant Genetic Resources for Food  
and Agriculture
General website: www.planttreaty.org 
ITPGRFA Text of the Convention and Annex 1: 
www.planttreaty.org/content/texts-treaty-official-versions
Collections included in the Multilateral System on Access 
and Benefit-sharing: www.planttreaty.org/inclusions 
World Intellectual Property Organization
Searchable database of actual and model biodiversity- 
related access and benefit-sharing agreements with 
 p articular emphasis on the intellectual property aspects of 
such agreements:
www.wipo.int/tk/en/databases/contracts/index.html 
 
Convention on International Trade in Endangered Species  
of Wild Fauna and Flora (CITES)
CITES general website: www.cites.org
CITES convention text:  
https://www.cites.org/eng/disc/text.php
CITES convention, Annexes:  
https://www.cites.org/eng/app/appendices.php 
CITES Management Authority in Switzerland:  
Federal Food Safety and Veterinary Office FSVO  
www.cites.org/eng/cms/index.php/component/cp/ 
country/CH 
www.cites.ch
Register of scientific institutions entitled to the exemption 
for non-commercial donation, exchange or loan of listed 
species: www.cites.org/eng/common/reg/e_si.html
 
European Union
EU ABS website includes: Legislation, registered 
 collections, background  material and links:
http://ec.europa.eu/environment/nature/biodiversity/ 
international/abs/index_en.htm 
 
Germany
Bundesamt für Naturschutz, ABS Deutschland:  
www.bfn.de/index_abs+M52087573ab0.html 
German Research Foundation 
Supplementary Instructions for Funding Proposals Con-
cerning Research Projects within the Scope of the CBD: 
www.dfg.de/formulare/1_021e/1_021e.pdf
Other Guidelines and Sources 
Botanic Gardens 
International Plant Exchange Network (IPEN), general 
website: 
www.bgci.org/policy/ipen 
Botanic Gardens Conservation International:  
learning modules for botanic gardens: 
www.bgci.org/policy/abs_learning
Micro-organisms Sustainable use and Access regulation 
 International Code of Conduct
http://bccm.belspo.be/documents/files/projects/ → mosaicc 
http://bccm.belspo.be/documents/files/projects/ → mosaics       
http://bccm.belspo.be/documents/files/projects/ → trust 
International Institute for Sustainable Development
ABS Management tool. Best Practice Standard and Hand-
book for Implementing Genetic  
Resource Access and Benefit-sharing Activities. A hand-
book that provides voluntary guidance to the users and 
providers of genetic resources and focuses on commercial 
research.  
Provides useful guidance on negotiating partnerships:  
www.iisd.org/library?keys=ABS+Management+Tool+
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V National Focal Point
Swiss National Focal Point to the Nagoya Protocol 
Soil and Biotechnology Division 
Federal Office for the Environment (FOEN) 
3003 Bern 
Switzerland
E-mail: contact.np @bafu.admin.ch
Who are we?
The Swiss Academies of Arts and Sciences link sciences regionally, nationally and internationally.  
They specifically engage in the fields of early warning and ethics and advocate for an equitable 
dialogue between science and society.
The Swiss Academies of Arts and Sciences is an association of the four Swiss scientific academies
– Swiss Academy of Sciences (SCNAT)
– Swiss Academy of Medical Sciences (SAMS)
– Swiss Academy of Humanities and Social Sciences (SAHS)
– Swiss Academy of Engineering Sciences (SATW) 
as well as the centres of competence 
– Centre for Technology Assessment (TA-SWISS) 
– Foundation Science et Cité 
SCNAT – network of knowledge for the benefit of society
The Swiss Academy of Sciences (SCNAT) and its network of 35 000 experts works at the regional, 
national and international level for the future of science and society. It strengthens the awareness for 
the sciences as a central pillar of cultural and economic development. The breadth of its support makes 
it a representative partner for politics. The SCNAT links the sciences, provides expertise, promotes the 
dialogue between science and society, identifies and evaluates scientific developments and lays the 
foundation for the next generation of natural scientists. It is part of the association of the Swiss 
Academies of Arts and Sciences. 
The Swiss Biodiversity Forum of the SCNAT is the scientific center of competence for biodiversity  
in Switzerland.
The purpose of this manual is to inform the academic community about the system governing  
access to genetic resources and Associated Traditional Knowledge and the sharing of the benefits  
arising from their use as established by the Convention on Biological Diversity and its Nagoya Protocol. 
The brochure explains the steps that researchers must take when accessing biological resources  
for research purposes and it informs about the ABS legislation in Switzerland.  
The manual is a Good Practice Guide in the sense of Art. 20.1 of the Nagoya Protocol.

